All publications and patents and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent or patent application was specifically and individually indicated to be incorporated by reference.
Aspects of the invention described herein relate generally to filters inserted into a patient's body and more particularly to the provision of echogenic coatings on such devices to enhance their visibility using one or more of in any combination ultrasound imaging, intravascular ultrasound imaging, greyscale intravascular ultrasound imaging, color intravascular ultrasound imaging or ultrasound image signal processing that included spectral analysis.
Ultrasonic imaging in the medical field is widely used for a variety of applications. In addition to imaging physiological structures and tissue such as organs, tumors, vessels, and the like, it is often desirable for a physician or technician to have an image of a medical device which has been inserted into the tissue or passageway of a patient. Still further, advancements in the use of intravascular or intraluminal imaging ultrasound (positioned either within or outside of the body) before, during and after procedures has led to increasing requirements for cooperation between device and imaging modality.
A variety of approaches have been used to enhance ultrasonic imaging of devices by increasing the acoustic reflection coefficient of the devices. While echogenic materials have been described for some uses in medical devices, the conventional uses of echogenic materials has not kept pace with the advancements in applications for imaging ultrasound. Moreover, while many approaches have been attempted, there is still need for improvements that are particular to the use of specific device designs. In particular, as medical therapies and procedures continue to advance, there is, in many medical instances, a need for more specific information about a device, its placement, position, orientation or aspect in relation to another object. What is needed are further improvements to the manner and placement of echogenic enhancements to obtain these additional benefits.
In general, in one embodiment, a filter includes a hub; and a plurality of legs or wires or segments extending from the hub; wherein at least a portion of the hub or a portion of one or more of the legs or wires or segments is modified to provide an enhanced echogenic characteristic of the filter.
This and other embodiments include one or more of the following features. In one aspect, the modification can provide an enhanced echogenic characteristic of the filter is a modification to a portion of the filter to enhance the echogenic characteristics of that portion of the filter. In another aspect, the modification can provide an enhanced echogenic characteristic of the filter which can be the formation of dimples into a surface of the filter. In yet another aspect, the dimples can be of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with an intravascular ultrasound system. In a further aspect, the modification can provide an enhanced echogenic characteristic of the filter which can be the formation of protrusions formed in, placed on or joined to a filter surface. In an additional aspect, the protrusions can be of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with an intravascular ultrasound system. In another aspect, the modification can provide an enhanced echogenic characteristic of the filter including the roughening one or more surfaces of a filter. In yet another aspect, the roughening can be performed using a chemical process, a laser or bead blasting technique. In still a further aspect, the roughening can be of sufficient scale to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems. In a further aspect, the modification can provide an enhanced echogenic characteristic of the filter including altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of the filter. In an additional aspect, the cavities, voids or pockets can be of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with an intravascular ultrasound system.
This and other embodiments include one or more of the following features. In one aspect, the filter can further include at least one fixation element. Any portion of the tissue anchor or any portion of one of the hub, the plurality of legs or wire or segments extending from the hub can be modified to provide an enhanced echogenic characteristic of the filter related to the use, status, position orientation of the at least one fixation element or the filter. In another aspect, the first and second support members, the crossover and the first end or the second end of the first support member, any portion of one of the above can be modified to provide an enhanced echogenic characteristic of the filter related to the use, status or of clot burden of the filter. In a further aspect, a method of positioning a filter within a lumen can include advancing a sheath containing a filter through the lumen, deploying a portion of the filter from the sheath into the lumen while maintaining a portion of the filter within the sheath, either of the above steps can be performed before or after using imaging from an intravascular ultrasound system. In an alternative aspect, a method of deploying a filter within a lumen can include advancing a sheath containing the filter through the lumen; and deploying the filter into the lumen, wherein, either step can be initiated, performed, confirmed or completed at least in part based on information obtained using intravascular ultrasound from one or more echogenic aspects of the filter. In yet another aspect, the method can further include maneuvering a snare towards the filter in a direction to retrieve the filter and engaging the snare with the filter. The maneuvering step or the engaging step can be initiated, performed, confirmed or completed at least in part based on information obtained using intravascular ultrasound from one or more echogenic aspects of the filter. In still another aspect, the method can further include engaging the lumen wall with a fixation element attached to the filter. This step can be initiated, performed, confirmed or completed at least in part based on information obtained using intravascular ultrasound from one or more echogenic aspects of the filter. In one aspect, a filter delivery catheter can be adapted and configured to deliver a filter according to any of the previously mentioned embodiments. A delivery catheter can be adapted and configured for delivery of an endoluminal filter, an IVUS transducer can be integrated into the distal portion of the delivery catheter, and one or more connectors on the proximal end of the delivery catheter can be adapted and configured to connect the IVUS transducer to an appropriate imaging or processing system. In another aspect, the filter delivery catheter can further include a telescoping sleeve within an moveable relative to the filter delivery catheter. In yet another aspect, the filter delivery catheter can further include a pusher rod within a moveable relative to the filter delivery catheter. In still another aspect, the IVUS transducer integrated into the distal portion of the delivery catheter can be adapted and configured whereby advancing and retracting the delivery catheter generates a plurality of images slices from the IVUS transducer. In a further aspect, the IVUS transducer integrated into the distal portion of the delivery catheter can be adapted and configured whereby advancing and retracting the delivery catheter can provide an output from the IVUS transducer for positioning guidance of a filter delivered using the delivery catheter. Is an alternative aspect, the IVUS transducer can be integrated into the distal tip or end of the delivery catheter. In yet another aspect, the delivery catheter can further include a pressure transducer. In still another aspect, the pressure transducer can be located proximal to the IVUS transducer. In one aspect, the delivery catheter can further include a filter as in any of the previously mentioned embodiments within the delivery catheter. In another aspect, a method of positioning a filter within a lumen can include advancing a delivery catheter according to any of the previously mentioned embodiments and can contain a filter as in any of the previously mentioned embodiments through the lumen using imaging information provided by the IVUS transducer on the delivery catheter to determine relative position before deploying a portion of the filter from the delivery catheter into the lumen to engage the lumen wall. In yet another aspect, the method can further include obtaining IVUS imaging of the lumen using the delivery catheter prior to deployment of the filter, after the deployment of the filter or during the deployment of the filter. In still another aspect, the method can further include obtaining IVUS imaging of the lumen using the delivery catheter for imaging a deployment location and estimating the sizing of a filter for the deployment location prior to performing any of the previously mentioned methods. In a further aspect, the method can further include estimating treatment duration using imaging data collected as in any of the previously mentioned methods. In an alternative aspect, a filter can further include an IVUS transducer integrated into the filter.
A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
Filters are more complex structures in contrast to the relatively simple designs found in catheters and needles. In a more complex device like a filter there is a need to identify specific portions within the device during some medical procedures. In addition, it would be advantageous as well to determine the orientation of the device including components within the device to one another (as used for determining deployment, retrieval and the various intermediate stages thereof) as well as the overall filter orientation to the surrounding lumen or vessel. In contrast to the conventional techniques using location of the tip or start or end of the entire length, a more complex structure such as a filter position, orientation or relative placement information would yield specific benefits. In some cases, aspects, portions or attributes of the overall filter or filter components or portions will enable more useful determinations about the filter in relation to the physiological environment. In one aspect, an intravascular ultrasound (IVUS) catheter and processing system or signal processing algorithm is used to confirm filter sizing selection, guidance for filter placement, filter implantation steps, filter and/or vessel measuring using IVUS before during and/or after steps to confirm sizing selection and fit is appropriate under the physiologic environment and for confirmation and/or documentation of proper sizing selection, placement, engagement or degree of engagement of fixation elements (if present), clot burden, orientation and/or deployment in a patient or physician medical record.
In one aspect, embodiments of the present invention are directed toward medical devices having a complex shape or that are configured to move from stowed to deployed configurations that may also have specific orientation and placement criteria for proper use in a lumen, vessel or hollow organ. One such complex device is an IVC filter. Aspects of the present invention include such devices employed within the human body which have enhanced ultrasound visibility by virtue of incorporation of an echogenic material using any of the techniques described herein alone or in any combination.
In one aspect, there are described herein various alternative filter designs for increasing the echogenicity of the filter. A filter with enhanced echogenic characteristics may include one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. One example of the manufacturing alteration is to introduce gaps between the segments of tubing or coverings whereby the gap provides the echogenic enhancement. In addition, cavities, voids, pockets, dimples, gaps and the like may be left empty or, optionally, filed, partially filed or lined with any of the echogenic materials described herein.
In one aspect, there are provided embodiments of a filter having enhanced echogenic characteristics in or related to at least one or a portion of: an proximal end, a distal end, a terminal proximal end, a terminal distal end, a retrieval feature, an atraumatic tip on a retrieval feature, a mid-strut region, a leg or strut portion having at least one orientation attribute to another portion of the filter, an indicia of a location of a fixation element or a retrieval feature, a location on a portion of the filter selected such that in use with a particular fixation element the marker in in a location that indicates that the fixation element is fully deployed into a wall of a lumen or portion of a vessel or hollow organ (i.e., the marker is against the lumen wall or nearly so when the fixation element is fully engaged. As such, see the marker against the wall indicates proper deployment, spaced from or not visible would indicate, respectively, not fully engaged or over penetration); a portion of the distal tip and/or an elongated portion. The above described methods may also be applied to the other techniques and alternatives described herein.
In still further embodiments, a portion, component or aspect of an intraluminal filter may have enhanced echogenic attributes by applying a coating or sleeve containing one or more of the echogenic materials disclosed herein or fabricated according to any of the techniques or having any of the attributes to enhance echogenic qualities as described herein. In some aspects, the enhanced echogenic attributes are provided by the incorporation into, application onto or within a component or portion of a filter one or more echogenic materials or echogenic markers in a specific configuration, location, orientation or pattern on the filter.
Enhanced echogenic markers or locations may be devised and placed for use individually or in combinations such as to facilitate the identification to an IVUS system or ultrasound imaging modality an indication or signature for a specific location on a filter, such as, for example, a retrieval feature, a terminal proximal end, a terminal distal end, a location of a fixation element or a location of some other indicia that identifies a specific aspect of a particular filter design. In addition or alternatively, two or more enhanced echogenic markers or portions may be used in combination to provide additional information about a filter such as orientation with in a vessel, confirmation of deployment or a portion of a deployment sequence, confirmation of final placement, confirmation of migration or lack of migration, confirmation of retrieval or progress in a retrieval sequence and the like according to the various processes and used for filters within the vasculature or in lumens of the body. In another specific embodiment, the use of IVUS techniques with embodiment of the echogenic enhanced filters describe herein may also be used to measure the diameter of the vessel at specific device locations indicated by the echogenic markers during or after deployment or retrieval of a filter.
In still further aspects, the use of IVUS techniques with embodiment of the echogenic enhanced filters describe herein may also be used to determine, detect or indicate inadequate dilation, adequate dilation, filter expansion, degree of filter expansion, filter—vessel engagement and degree or engagement, strut/leg/anchor position and other attributes relating to the interaction between the filter and the surrounding physiological environment.
Still further, the echogenic markers are positioned with regard to the likely or planned positioning of the IVUS transducer and/or likely pathways for acoustic energy used by the imaging system. By way of example, if the IVUS transducer is forward looking, then those forward looking aspects of the filter will be provided with the enhanced echogenic aspects. In another example, if the IVUS transducer is cylindrically shaped and will be positioned through the interior portion of a filter then the filter will be provided with enhanced echogenic aspects on interior surfaces or portions that would receive acoustic energy from such as transducer in such a position. Other modifications are within the scope of the invention based on the particular style of IVUS transducer used, the position relative to the filter and the placement and type of echogenic feature incorporated into the filter. Put another way, the echogenic enhancements of the filters described herein are selected, designed and positioned on the filter with regard to the IVUS sensor type, acquisition mode and position relative to the filter. Additional details in the use of IVUS with filters is further described in U.S. Pat. Nos. 6,645,152 and 6,440,077, both of which are incorporated herein by reference in their entirety for all purposes.
In one aspect, the placement and signature of such enhanced echogenic markers are discernible to a human user viewing an ultrasound output alone or in combination with being discernible to a computer system configured for the processing of an ultrasound return including a return from the enhanced echogenic filter.
In various alternatives, the echogenic material may either be applied to a portion of or a component of a filter in any of a number of different techniques.
In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a selective coating applied to a portion or component of a filter.
In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a mold formed to be placed over or joined to a portion of component of a filter.
In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as an extruded sleeve formed in a continuous segment to cover a portion or component of a filter. In one embodiment, one of the inner tubular member or the outer sleeve or coating may be fabricated of a material according to the present invention, having increased echogenicity, with the other of the inner tubular member fabricated of a biocompatible polymer such as polyurethane or silicone rubber, for example.
In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a compound or two layer structure comprising an inner tube and an outer tube or sleeve with one or both of the tubes made from or including or incorporating one or more echogenic materials or modifications as described herein. In addition or alternatively one or both sleeves, tubes described herein may include or encapsulate an echogenic marker or component of specific shape or geometry, for example, as in the case of a tube structure having within the sidewall of the tubing a coiled structure. In one aspect, the coiled structure is made from an echogenic material and the windings are provided in a manner that is useful in any of the aspects of the filter described herein. The coil may have a particular size or variation in size, pitch or variation in pitch or other attribute useful in providing an echo identifiable aspect of the filter property being determined. In one specific embodiment, the dimensions of the coil or other echogenic material has dimensions selected for increasing acoustic reflection with regard to the resolution or processing algorithms used in the imaging ultrasound system.
In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a braided structure incorporated into a compound or two layer structure comprising an inner tube and an outer tube or sleeve with one or both of the tubes made from or including or incorporating one or more braid comprising echogenic materials or modifications as described herein. In addition or alternatively one or both sleeves, tubes described herein may include or encapsulate an braid formed into an echogenic marker or component of specific shape or geometry, for example, as in the case of a tube structure having within the sidewall of the tubing a braided structure. In one aspect, the braided structure is made from an echogenic material and the braided is a small diameter that is when wound around the tubes or sleeve or directly onto a portion of or component of a filter. The winding pattern and spacing of the braided materials are provided in a manner that is useful in any of the aspects of the filter described herein. The braid may have a particular braid strand composition, structure, size or variation in size, pitch or variation in pitch or other attribute useful in providing an echo identifiable aspect of the filter property being determined. One or more of the strands in the braid may be formed from an echogenic material. One or more of the strands may be formed from a material having improved radiopaque characteristic. One or more of the strands may be formed from a material having both echogenic and radiopaque properties. The strands of a braid may be combined using any of the above described strand characteristics.
In another alternative, in still another example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as the a series of short segments placed adjacent to one another along a portion or component of a filter in either a close packed or spaced arrangement. In another embodiment, the spacing or voids between adjacent segments may also be adjusted or selected so as to enhance echogenic capabilities of the filter using the material difference introduced by the spacings or voids.
In another alternative, in still another example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a tubing or sleeve suited to heat shrink operations. In one aspect, there is a manufacturing or assembly steps of sliding one or more sleeves over portion of the filter then apply heat to shrink down the segment about the portion of the filter. In particular, various embodiments provide for the specific placement of such a shrink fit tubing having enhanced echogenic characteristics as described herein. It is to be appreciated that the sleeves, segment or tubes may be provided from or have echogenic modifications or elements incorporated into suitable materials such as, for example, ePTFE, PTFe, PET, PVDF, PFA, FEP and other suitable polymers. Still further, these and other materials may be formed in shapes other than tubes but may also take the form of strands, lines, fibers and filaments to be applied in accordance with the echogenic enhancement techniques described herein. In some embodiments, the tubes or segments applied to a filter may have the same or different composition as well as have the same width or different widths. In one aspect, the width or thickness of a plurality of bands is used to provide a code or information about the filter. The use of echogenic bands of different widths is a marking technique similar to the way that different size and color rings on a resistor are arranged in a pattern to describe the resistor's value.
In another alternative, in still another example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter is extruded over a portion of or a component of the filter.
In another alternative, in still another example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter is by bonding an echogenic material or components to the filter using a suitable adhesive or bonding technique.
In any of the above described configurations, the portion or component of the filter may be modified with dimples, grooves, pockets, voids. In other aspects, there may be one or more full or partial circumferential recesses, rings, surface diffraction gratings or other surface features to selectively enhance or provide an echogenic property in that portion of the filter, to aid in or foster the application of the echogenic materials. In still further aspects, any of above described surface modifications may also be used to uniquely identify a portion of a filter or any of the above in any combination.
In still further aspects of any of the above echogenic markers or attributes the thickness of the sleeve or coating or component may decrease at its proximal and distal ends to provide for a smooth outer surface. As yet an additional alternative, a coating, marker or other echogenic material may extend proximally to or closely adjacent to the distal end or the distal end or both of the filter component or filtering device.
In still other alternatives or combinations, some filter design embodiments alter components of the filter to enhance echogenicity such as, for example, material selection to incorporate echogenic materials. Examples of echogenic materials include palladium, palladium-iridium or other alloys of echogenic materials.
In some embodiments, echogenic microbubbles are provided in a portion of a filter to enhance the acoustic reflections of that aspect of the filter. Echogenic microbubbles may be prepared by any convenient means and introduced into the component or portion thereof or by a coating or sleeve or shell or other transferring means or mixed with a polymer or other suitable base compound prior to extension of extrusion, molding casting or other technique. The echogenic microbubbles may be pre-prepared or prepared inside the component or element or marker as appropriate. Aspects of the preparation or use of microbubbles are described in U.S. Pat. Nos. 5,327,891; 4,265,251; 4,442,843; 4,466,442; 4,276,885; 4,572,203; 4,718,433 and 4,442,843. By way of example, echogenic microbubbles can be obtained by introducing a gas, e.g. carbon dioxide, into a viscous sugar solution at a temperature above the crystallization temperature of the sugar, followed by cooling and entrapment of the gas in the sugar crystals. Microbubbles can be formed in gelatin and introduced into a component or portion of a device. Microbubbles can also be produced by mixing a surfactant, viscous liquid and gas bubbles or gas forming compound, e.g. carbonic acid salt, under conditions where microbubbles are formed.
In still further alternatives, there is also the incorporation of dual mode materials (radiopaque and echogenic) into a polymer then used to form part of, be applied or otherwise incorporated with a filter device as described herein. Some of these polymer compounds may be fabricated to enhance aging and shelf life and have other beneficial attributes. In one aspect, a filter or portion thereof includes one or more selected segments that are constructed using visibility materials compounded with one or more polymeric materials that make the selected segments visible using both fluoroscopy and ultrasonic imaging. In one specific example, the visibility material may take the form of tungsten and/or tungsten carbide particles dispersed within a polymeric material. In one specific aspect, the radiopaque and echogenic material includes tungsten and/or tungsten carbide particles distributed within a base polymeric material.
In one embodiment, a portion of or a component of a filter includes or has been modified to have an inner layer including a radiopaque and echogenic material. In one alternative, the radiopaque and echo genic material includes particles distributed within a base polymeric material (i.e., a first polymeric material) including a polyether block amide; and an outer layer including an additional polymeric material (i.e., a second polymeric material). In certain embodiments, the additional polymeric material is a thermoplastic elastomer. Optionally, the additional polymeric material is more resistant to hydrolysis and/or oxidation than the base polymeric material.
In still further aspects, a component, a portion or an element added to a filter may be regarded as an echogenic body member that is a part of an echogenic filter to be sonically imaged. The echogenic body member is at least partially made up of a composite material which is echogenically imageable in the patient, such as by the use of ultrasonic imaging equipment used either within the patient or external to the patient. In one aspect, a composite material includes matrix material with discrete acoustic reflective particles embedded in matrix material. In one aspect, the matrix material is a biocompatible plastic. Examples of suitable plastics may include urethane, ethylene, silicone, polyethylene, tetrafluorethylene. In one aspect, a matrix is a formable, pliable material which may be molded and/or extruded to a variety of shapes, depending upon a specific application. The sound reflective particles are embedded in matrix material. Particles are, by way of example, made of a hard material, such as small glass particles that are solid or filled with an acoustically reflective medium. In one aspect, glass particles having a generally spherical shape forming glass microspheres. Glass microspheres with an outer diameter of about 5 microns is one acceptable size. Other sized particles may be utilized as, for example, ranging between 1 and 50 microns and beyond. Particles sized below the resolution size of the imaging ultrasound system in use may be arranged into patterns of sufficient size and orientation to the acoustic waves that result in a discernible feature by the imaging ultrasound system. Furthermore, the particles do not necessarily have to be spherical, or may be partially spherical. Still further, the shape of the particle could be altered to enhance acoustic reflection by presenting different shapes of particles, sizes of particles and combinations thereof to modify acoustic characteristics of the matrix material. By way of example, the particles may be shaped into an “Ordered array.” “Ordered arrays” can take the form of a macrostructure from individual parts that may be patterned or unpatterned in the form of spheres, colloids, beads, ovals, squares, rectangles, fibers, wires, rods, shells, thin films, or planar surface. In contrast, a “disordered array” lacks substantial macrostructure.
By way of example, an echogenic marker may comprise particles that individually are below the resolution of the imaging ultrasound system. The echogenic marker is the combination of these below imaging ultrasound resolution particles in combination, in 1D, 2D or 3D patterns, in graphic arrays, or in machine readable combinations to make a signature. Based on the specific characteristics of the combination of particles, the acoustic returns from an echogenic marker or combination of echogenic markers may be visually perceptible in a display for interpretation by a user or may be detected and interpreted by one or more acoustic reflection or spectral processing algorithms within a imaging ultrasound processing system.
In one aspect, the echogenic material is fabricated by incorporating nanometer sized particles of sonically reflective materials, for example iron oxide, titanium oxide or zinc oxide into a biocompatible polymer. In one method of fabrication, the acoustically reflective particles are mixed with a powdered thermoplastic or thermosetting material such as a polyether amide, a polyurethane or an epoxy, or polyvinylchloride followed by thermal processing of the mixture to provide a material of increased sonic reflectance which may be applied as a coating on medical devices of the type discussed above or may be incorporated as a structural component of the medical devices as described herein.
In still further embodiments and aspects, the particles included to provide echogenic enhancements may be selected, arranged or incorporated to provide acoustically geometrically tuned nanostructures, microstructures or macrostructures. The particles provided herein are formable in all shapes currently known or to be created for acoustic reflection enhancement. In non-limiting examples, the nano-, micro- or macro-particles are shaped as spheres, ovals, cylinders, squares, rectangles, rods, stars, tubes, pyramids, stars, prisms, triangles, branches, plates or comprised of an acoustically reflective surface or where one or more surfaces is adapted such as by roughening or dimpling or other technique used to alter acoustic reflection properties. In non-limiting examples, the particles comprise shapes and properties such as plates, solid shells, hollow shells, rods, rice shaped, spheres, fibers, wires, pyramids, prisms, or a combination thereof.
In one specific aspect, a partially spherical surface may be provided on the outside and/or the inside of particles, as for example a particle with a hollow spherical space therein. Particles are made up of a different material than the matrix. While desiring not to be bound by theory, it is believed that a spherical shape provides for sound reflections at a variety of angles regardless of the direction from which the ultrasonic sound waves are emanating from, and accordingly, are more likely to reflect at least a portion of the transmitted signal back to the ultrasonic receiver to generate an image. Since many of matrix materials available are relatively ultrasonically transparent in a patient, sound reflective particles provide adequate reflection. The use of a composite, rather than a solution, provides adequate size for acoustic reflection off of the discrete particles embedded in the matrix. As indicated, a variety of materials may be utilized for the sound reflective particles, such as aluminum, hard plastic ceramics, and, metal and/or metal alloys particles, and the like. Additionally, liquids, gases, gels, microencapsulants, and/or suspensions in the matrix may alternatively be used either alone or in combination, so long as they form a composite with the desired ultrasonically reflective characteristic.
Any of the above embodiments, alternatives or filter modifications to enhance echogenic characteristics may also be designed or implemented in such a way as to provide an echogenic identifiable or unique trait or acoustic reflection signature that may be registered by a human operator looking at a display or identified using signal processing techniques of a return containing acoustic reflections from the filter in an imaging ultrasound system. In one example, there is a surface of the filter having one or more echo registerable or identifiable feature, mark or indication in a position useful for determining one or more of: a location of an end of a filter; a location of a fixation element on a filter; a location of a retrieval feature on a filter; an orientation of one or more of a leg, a strut, a filter or an end of a filter relative to another of a leg, a strut, a filter or an end or the orientation of the overall filter to a lumen, vessel or hollow organ in a body. Moreover, in another widely applicable aspect of providing enhanced imaging characteristics to a filter as described herein, the characteristic or modification—however added or incorporated into the filter—enable a filter, a filter component or a specified portion of a filter to be more readily imaged by intravascular ultrasound as described herein. In still another aspect, the characteristics or modification to the filter are oriented and positioned in order to facilitate IVUS imaging via an IVUS probe borne by a filter deployment or retrieval catheter, snare, or other implement provided to facilitate the use of intravascular filters.
Also illustrated in
Echogenic characteristics may be added to each of the sections based on the type of function being measured or characterized. For example, echogenic markers, features or tags may be added to Section A in order to provide, for example: identification of the terminal end, end portion or retrieval portion of a filter. Echogenic characteristics of Section A may also be used for determinations related to Section A specifically or the filter generally of filter position, positioning, attitude within the lumen, localization of the filter within the vasculature and other traits common to the characterization of intravascular devices. For example, echogenic markers, features or tags may be added to Section B in order to provide, for example: identification of the mid strut portion, middle or capture region. Echogenic characteristics of Section B may also be used for determinations related to Section B such as for sizing, centering, symmetry of implantation, placement, apposition of implant to vessel walls, clot burden, deployment status or completion, gauge of filter capacity and/or filter contents as well as filter position, positioning, attitude within the lumen, localization of the filter within the vasculature and other traits common to the characterization of intravascular devices. For example, echogenic markers, features or tags may be added to Section C in order to provide, for example: identification of the rear portion, terminal end, retrieval feature, anchor location or depth of insertion, perforation indication or other aspects of the rear or proximal portion of a filter. Echogenic characteristics of Section C may also be used for determinations related to Section C such as for sizing, centering, symmetry of implantation or placement of legs struts and the like, as well as for determination of wall apposition, anchor penetration or perforation. Still further, the markers or tags may be added to aid in determining or evaluating filter position, positioning, attitude within the lumen, localization of the filter within the vasculature and other traits common to the characterization of intravascular devices.
A filter having enhanced echogenic properties is illustrated in
The filter 10 includes a plurality of elongated legs 16 which are of equal length and are identically configured to each other. The legs 16 are collectively arrayed in a conical geometric configuration so that the legs converge to the apical hub 14, and are symmetrically spaced about a central axis extending through the hub. Each of the legs is of equal diameter over its entire length and is made of a relatively resilient material, such as tempered stainless steel wire or the like. In addition to the echogenic attributes described herein, the legs may be coated with a polymeric, synthetic resin material having anti-thrombogenic properties.
The filter 10 includes an apical hub 14 of overall egg-shaped or tear drop configuration and which has a generally hemispherically shaped end portion 14a. This construction avoids impalement of the filter on the blood vessel walls during emplacement, and also avoids irritation or scratching of the blood vessel during insertion of the filter. The apical hub 14 is drilled for the reception of the end portions of a plurality of legs as hereinafter described.
The filter 10 includes a plurality of elongated legs 16 which are, in some embodiments, of equal length and are identically configured to each other. In one aspect, the legs 16 are collectively arrayed in a conical geometric configuration so that the legs converge to the apical hub 14, and are symmetrically spaced about a central axis extending through the hub. Each of the legs is of equal diameter over its entire length and is made of a relatively resilient material, such as tempered stainless steel wire or the like. The legs may be coated with a polymeric, synthetic resin material having anti-thrombogenic properties. In the embodiment of the filter illustrated, six of the legs 16 are provided, and since each of these legs is identical to every other leg, only one of the legs will be described in greater detail.
At its outer end, or end which is distally located with respect to the apical hub 14, each leg is reversely bent through an angle of more than 90°, and is tapered or sharpened to a point 16a. The reverse bend is outwardly in a direction away from the central axis of the conical figure. As depicted in
It will be seen in
The wires forming legs 12 are formed into first linear portion 13, second multi angled portion 16 and hook 22 against a steel guide in such a way that there is an alternating bend circumferentially oriented to produce a characteristic conical structure. Hook 22 has length LH, about 1.8 mm, and is angled at angle θH, about 34°. The bends 38 in leg wires 12 are formed by bending the wires at an angle of 130°-150°. Hook 22 is formed mechanically by bending the distal end of wire 12 over a mandrel. Hook 22 is then sharpened on three sides against an abrasive wheel. Nose bend 15 is made to form first linear portion 13 near to bead 14, parallel to axis E of filter 10. The leg 12 then bends slightly outwardly on the major angle of the cone and passes through a series of bends as described above.
The embodiment of the filter described above with regard to
The filter 10 includes a plurality of elongated legs 16 which are of equal length, and are preferably identically configured to each other. The legs 16 are collectively arranged in a generally conical geometric configuration so that the legs 16 converge in the apical head 14, and are symmetrically spaced about a central longitudinally disposed axis “L”, which is shown extending through the head 14, in
At its outermost end 18 which is distal with respect to the apical head 14, each leg 16 has a main portion 20 and a reversely bent portion 22 which is bent through an angle of about 180° in the plane which is tangential to the conical configuration of the legs, and is disposed parallel and contiguous to the main portion 20. A pointed tip portion 24 of the leg which comprises a hook, extends generally radially outwardly, away from the main portion 20 at an angle of from 70° to about 90°, which tip portion 24 is shown piercing a cava wall 26.
A further embodiment of a vena cava filter 60 is shown in
A typical leg 64 is each mounted in a bore 68 in the apical head 62, which bore may be parallel to the center line of the filter 60. Each bore 68 receives only about 0.19 inches of the proximalmost end of each leg 64. When all the legs 64 are filling their proper respective bores 68, they are preferably welded therein. Each leg 64, in addition to having a plurality of U-shaped bends 70, disposed in the plane tangential to the cone defined by the legs 64, and intermediate their proximal and distal ends, as recited in the aforementioned incorporated patent, has a first slight bend 72 having a radius of curvature RI of about 1.4 inches arranged immediately adjacent the apical head 62, to cause the leg(s) 64 to flare radially outwardly about 18 degrees, thus defining their cone shaped configuration. This flare permits the filter 60 to have enough elastic recoil to assume its general conical configuration, which is desirable to permit the filtration of blood clots while still allowing blood to flow around the captured clots, thus promoting dissolution of any clot and maintenance of vessel patency. The filter 60 with this flare can be passed through small delivery carriers without exceeding the elastic limit of the stainless steel filter legs 64.
The apical head 62 on the filter 60 has a central cylindrically shaped bore 80 which is adapted to receive inself aligning engagement, a guidewire (not shown). The bore 80 critically has its cylindrical portion which is in axial alignment with the longitudinal center line “L” of the filter 60. Each end of the bore 80 has a tapered counterbore 82 to permit access of a guidewire into the bore 82. This permits the filter 60 to be aligned and centered along the axis of a guidewire in a vessel during (and after) filter emplacement therein.
The embodiment of the filter described above with regard to
Struts 24 may be fabricated from wire with a circular or rectangular cross section. For example, struts 24 may be comprised of 2 inch lengths of 0.018″ diameter wire. Stainless steel, titanium, and nickel-titanium alloys have all been found to be acceptable materials for struts 24. In the embodiment of
In the embodiment of
Struts 24 radiate outwardly from body member 22 such that thrombus filter 20 is generally conical in shape. When thrombus filter 20 is deployed inside a blood vessel, free ends 28 engage the blood vessel wall. Body member 22 is held in a position proximate the center of the blood vessel by the plurality of struts 24 which engage the blood vessel walls with opposing force vectors.
When thrombus filter 20 is disposed in a blood vessel, the conical formation of struts 24 acts to trap, or capture blood clots. The generally conical shape of the formation of struts 24 serves to urge captured blood clots toward the center of the blood flow. The flow of blood around the captured blood clots allows the body's natural lysing process to dissolve the clots.
To assure firm attachment of thrombus filter 20 to the blood vessel walls, anchor portions 30 may be formed at free ends 28 of struts 24.
Blood vessel wall 32 is lined with a thin inner membrane or intima 44. When anchor portion 30 is embedded in wall 32 it punctures inner membrane 44. The body responds to a puncture of inner membrane 44 with a process known in the art as neointimal hyperplasia. The punctured area of inner membrane 44 is overgrown with a number of new cells. Referring again to
It is desirable that the thrombus filter of the present invention can be removed using minimally invasive methods without complications due to neointimal hyperplasia encapsulation of anchor portions 30 of struts 24. A process which may be utilized to remove thrombus filter 20 from a blood vessel 90 is schematically represented in
A removal catheter 100 with a lumen 102 and a distal end 104 is also disposed in lumen 92 of blood vessel 90. Removal catheter 100 enters the patient's vascular system at a point which is readily accessible to the physician. Once in the vascular system, catheter 100 is urged forward until distal end 104 is proximate thrombus filter 20. For example, if thrombus filter 20 is located in the inferior vena cava of a patient's vascular system, removal catheter 100 may enter the vascular system at the femoral vein. Alternately, if thrombus filter 20 is located in the superior vena cava of a patient's vascular system, removal catheter 100 may enter the vascular system at the jugular vein. In either case, the filter removal procedure can be minimally invasive, and not require general anesthesia.
Distal end 104 of removal catheter 100 is urged forward so that body member 22 of thrombus filter 20 is disposed inside lumen 102 of removal catheter 100. A force F is applied to thrombus filter 20 urging body member 22 further into lumen 102 of removal catheter 100. The magnitude of force F is of sufficient magnitude to break struts 24 at weakened portions 40. When struts 24 are broken at weakened portions 40 thrombus filter 20 including struts 24 may be pulled into lumen 102 of removal catheter 100. Removal catheter 100 may then be removed from the body of the patient by withdrawing removal catheter 100 from blood vessel 90. Thus, thrombus filter 20 is removed from blood vessel 100 but anchor members 30 remain attached to walls 32 by encapsulating cell growth 46.
Force F may be applied to thrombus filter 20 using a variety of methods. For example, the pulling of thrombus filter 20 into lumen 112 of retrieval catheter 110 may be accomplished with a retrieval wire including a hook. The retrieval wire may pass through bore 23 of body member 22. With the retrieval wire disposed in bore 23 of body member 22, the hook may engage body member 22 so that a pull force can be applied to thrombus filter 20.
Struts 24 may also be intentionally broken at weakened portions 40 by repeatedly deflecting struts 24 to induce fatigue cracking at weakened portions 40. The magnitude of the force required for this removal method is less than the magnitude of force required to break struts 24 without fatigue cracking.
A number of methods may be used to deflect struts 24. First, a pull force may be applied to thrombus filter 10 as shown in
The embodiment of the filters described above with regard to
Filter 10 includes six strands of stainless steel wire which are connected to each other in the following manner. Innermost strands 11 and 12 are mutually attached at both ends by crimps 13 and 14. Innermost strands 11 and 12 are approximately 25 centimeters in length and are made from 0.007 inch diameter coil wire. Outermost strands 15 and 16 are located oppositely of innermost strands 11 and 12 and are each connected thereto at both ends by wire strands 17 and 18. Outermost strands 15 and 16 are approximately 38 centimeters in length and are made from 0.007 inch diameter coil wire. Wire strand 17 serves to connect outermost strands 15 and 16 with innermost strands 11 and 12 at the distal end of filter 10. In a similar manner, wire strand 18 connects outermost strands 15 and 16 with innermost strands 11 and 12 at the proximal end of filter 10. Wire strand 17 is secured to outermost strands 15 and 16 by crimps 21 and 22, respectively and to innermost strands 11 and 12 by crimp 13. In a similar fashion, wire strand 18 is secured to outermost strands 15 and 16 by crimps 19 and 20, respectively, and to innermost strands 11 and 12 by crimp 14. Wire strands 17 and 18 are approximately 10 centimeters in length and are made from 0.010 inch diameter stainless steel coil wire. Crimps 19-22 are made from 3 mm, of 22 GTW cannula while crimps 13 and 14 are made from 3 mm, lengths of 19.5 GTW cannula. Innermost strands 11 and 12, and outermost strands 15 and 16 are made from a shape memory material, such as spring temper stainless steel.
During manufacture, wire strands 11, 12, 15 and 16 are curled in different directions and wadded together to form a curly wire mesh. Because of their shaped memory construction, innermost strands 11 and 12 and outermost strands 15 and 16 may be straightened out at their ends substantially as shown in
Anchoring filter 10 within a body blood vessel, such as the inferior vena cava, is generally provided by fixation elements at 24 and 25, the details of their construction being more clearly understood by reference to
Referring particularly to
It is to be understood that there are two forward anchor 25 at the forward end of filter 10. As previously mentioned, forward anchor 25 is of a similar construction to anchor 24 except that a barb 30 is received over the end length of wire corresponding to length 26 of anchor 24. The purpose of barb 30 is to provide a more secure anchor at the downstream end of filter 10 and thereby ensure long term patency of the filter. Barbs 30 are secured to the forward ends of the outer most wire strands 15 and 16 by soldering. Each of the barbs 30 have a lancet beveled portion 31 which faces outwards of filter 10 and a hooked portion 32 at the inwards facing end. Hooked portion 32 serves to prevent barb 30 from becoming dislodged from the body blood vessel once penetration thereof has been made. Each of the barbs 30 is constructed from 6 mm, to 0.028 inch diameter cannula.
In addition to the anchoring points at barbs 30,
The embodiment of the filter described above with regard to
In its normal expanded configuration or performed filtering shape, filter 10 is a double filter, having a first filter basket 16 and a second filter basket 18. The two filter baskets provide peripheral portions which engage the inner wall of the vein at two longitudinally spaced locations. The two filter baskets are generally symmetrical about a longitudinal axis passing through filter tip 13.
The mesh of first filter basket 16 is formed from the sections of wires between the two quarter-inch coils 12 and 14. The mesh is made up of a series of seven overlapping loops 20 arranged to form a rosette approximately 25 mm in diameter. The loops are angled slightly relative to the long axis of filter 10 and this angle can be varied to accommodate somewhat smaller diameters if the device is to be constrained in a tube of less than 25 mm in caliber. The loops 20 effectively divide the cross-sectional area to be filtered. The rosette formed by loops 20 can expand or be compressed to fit various sizes of vein. The peripheral portions or tips of the loops 20 press outwardly against the inner wall of the vein, although without becoming imbedded in the vein; loops 20 thereby help to keep filter 10 in place. First filter basket 16 is convex relative to filter tip 13.
The mesh of second filter basket 18 is formed by the six circumferentially spaced free wire ends or legs 22, which tilt and bow outwardly of the long axis of filter 10. The seventh wire terminates within sleeve 14 for use in inserting filter 20. The six free ends or legs 22 that extend beyond the second quarter inch coil 14 diverge so that their tips form a circle 24 of approximately 40 mm in diameter at their maximum divergence. Each leg is also bowed outwardly slightly. The legs serve to orient the device relative to the long axis of the vena cava. Second filter basket 18 is convex relative to filter tip 13.
In another alternative embodiment the legs are tilted outwardly but are not formed with a bow. In such an embodiment, second filter basket 18 opens away from filter tip 13 without being strictly convex.
Each free end of leg 22 is bent sharply outward at about a right angle to form a hook 26 of approximately 1.5 mm in length. The hooks are intended to engage the wall of the vena cava to prevent migration proximally or distally.
The six legs 22 are of slightly different lengths to permit good packing within the delivery device, as will be described; if legs 22 are all of a single length, the hooks may interfere with one another, so that the filter does not expand properly when delivered into the vein.
In
Still referring to
The embodiment of the filter described above with regard to
Each leg comprises a central element 1a, 2a, 3a, and 4a bent into a smooth quasi-halfsinusoidal form and having a reversely turned anchoring hook 1b, 2b, 3b and 4b at its distal end with respect to hub 5 as well as two symmetrical curved side elements 1c, 2c, 3c and 4c, and 1d, 2d, 3d and 4d extending on either side of the central element.
In the embodiment shown the two side elements of each leg 1 to 4 are formed from one piece of wire the ends of which are held together in hub 5, whereas at the middle of its length the wire piece forms an eyelet 7, 8, 9 and 10 surrounding the central leg element to be freely slidable along a part of the length thereof.
From the unfolded tulip-like configuration illustrated in
The side elements of each leg have a length and curvature such that in the unfolded tulip-like configuration of the filter the maximum distance between the side elements is of the same order as the distance between neighboring side elements of two adjacent legs. Moreover, the length and curvature is preferably chosen such that after insertion into the vena cava inferior the eyelets 7-10 will be positioned substantially at the inner side of the wall of the blood vessel.
As best seen in
The embodiment of the filter described above with regard to
The embodiment of the filter described above with regard to
With reference firstly to
In accordance with the invention, the filter fingers consist of flexible wires 8. They may in particular consist of metal wires, for example of a suitable grade of stainless steel. The diameter of the wires may be between 2 and 4 tenths of a millimeter for example 3 or 3.5 tenths of a millimeter.
These fingers are combined in groups of two adjacent fingers by a wire part which is folded in the manner of a hairpin 9 and forms said runners. As a result, the fingers are in the general shape of a clip 10. Advantageously, the filter preferably comprises at least six of the above fingers connected to three wire portions folded in the manner of a pin and distributed in an angular manner so as to ensure that the filter has good axial stability.
Referring to
In order to be introduced into the vessel, the filter 1 can adopt a constrained state in which the elongated branches or legs 3 are moved close up to the axis 18 of the central opening of the filter until they are substantially parallel thereto. When it is in place in the vessel, the filter adopts a radially expanded state, the branches 3 then moving away from the axis 18 and the hooks 5 anchoring themselves in the vessel wall.
The embodiment of the filter described above with regard to
In
As shown in
As appears from
In
A plurality of anchoring legs 6, in the example five, are secured in the right-hand ferrule 4 of
The embodiment of the filter described above with regard to
Referring now to the drawings,
These filtering section 2 are advantageously constituted by an assembly of flexible filiform elements 4 joined together by one of their ends to form substantially the envelope of a cone, ogive or the like.
In this way, this assembly of filiform filtering elements 4 will be permeable to the blood flow, indicated by arrows 5, but adapted to retain the clots. To that end, it will be disposed in the direction of the blood flow, i.e. the apex of the cone or the like will be directed substantially in the same direction as the blood flow.
By way of example, the flexible rods 4 will be six in number and made of a biocompatible material, such as a suitable metal alloy or plastics material. However, these materials will be chosen for their aptitude to elasticity and to deformation.
In fact, the rods 4 will represent a good flexibility in order, on the one hand, to be folded in a catheter of small dimensions and, on the other hand, to open out correctly in the blood vessel to form a barrage at the latter's dimensions.
Furthermore, the filiform filtering elements 4 will be such that they are non-aggressive with respect to the inner walls of the vessel.
More precisely, as shown in
The embodiment of the filter described above with regard to
Referring now to the drawings, and firstly to
Each connecting piece is constituted by a substantially cylindrical, hollow piece, the connecting pieces 4 and 5 presenting different internal diameters.
Legs 1, in the out-spread state for use, are angularly distributed in substantially regular manner, for example spaced apart successively in two's by about 60°.
Each leg 1 comprises a convex portion, whose apex 6 is adapted to abut against the inner wall of the vein 7 when the legs are in out-spread state for use.
This convex portion, which may for example be made by burnishing, is closer to one end of leg 1 than the other, with the result that, the legs being identical and mounted successively in two's in opposite direction, said filter abuts on the vein, at the level of apices 6, via two series of points spaced apart longitudinally by a predetermined distance.
The embodiment of the filter described above with regard to
As shown in
As shown in
The embodiment of the filter described above with regard to
In some aspects, any of the above described filters may be modified to include hybrid or dual mode features. One example of a dual mode feature is one that is both radio opaque and also echogenic. In still another aspect, the above described filters may also include a material capture structure as described below, with or without one or more imaging modes as described herein.
In still other alternative embodiments, there is provided a material capture structure having one or more echogenic enhancements alone or in combination with radiopaque enhancements. In one aspect, the filter structure used in a filter includes both echogenic and radio opaque enhancements.
An one aspect, the filter includes material capture structure in the IVC filter will be viewable under fluoroscopic and ultrasound imaging modalities, including appropriate echogenic characteristics to enhance the view of the status or condition of the material capture structure while using IVUS. Enabling the material capture structure to be viewed will allow the physician to appropriately center and verify placement of a filter.
In one aspect, the filter elements or structures are doped to incorporate one or more of echogenic or radio opaque materials or treatments. In one aspect, the filaments or strands or other structures used to form the filter structure or webbing of the filter includes a radiopaque material having high echogenic properties, such as tungsten or gold, but not limited to either.
In other embodiments, one or more filaments or portions of a filament within a material capture structure includes one or more non-metallic echogenic features, such as those described elsewhere in this specification. For example, a filament or portion thereof may include air pockets either added to the material or by the use of materials with entrained air or gas that are used. In one embodiment, an ePTFE suture has echogenic properties due to air content of the ePTFE material. In other aspects, a suture material or a filament or polymer strand may also include dimpled/roughened/matrix/sponge materials, additives, or modifications to provide or enhance the overall echogenic nature of the suture, filament, material or material capture structure, in whole or in part.
In one aspect, these additional materials may assist the physician in centering or placing a filter within a vessel. In another aspect, this improvement is used in conjunction with IVUS will enable the adequate viewing of the filter portion of the filter and will allow for co-registration of filter placement along with an accurate entry/removal of the catheter through the webbing of the filter.
The advantages of this inventive aspect of a filter include, for example and not limitation, filter placement, accurate representation of filter location, ease of introducing/retracting catheter, more viewable space for more accurate assessments, ability to co-register filter location with IVUS and/or ability to better place filter in desired location.
Still other aspects of the use of the innovative filter include, for example, deployment of filters, positioning of filters, sizing of filters, and estimated treatment lengths as well as suture and/or material capture structure visibility. In still other aspects of the use of the innovative filter include, for example, deployment of a vena cava filter, positioning of an IVC filter, sizing of an IVC filter, and estimated treatment lengths as well as enhanced suture visibility.
In one embodiment, there is an IVC filter delivery system with an enclosed IVC filter. This filter would have a mesh, suture, web or other material capture structure suited to the anticipated filter use. The mesh, suture, web or other material capture structure has one or more components that is doped with a highly radiopaque material for better visibility under flouro and good echogenicity for better viewing under IVUS guidance. In still further alternative embodiments, the techniques described above may be applied to one or more material capture structure described in U.S. Patent Application Publication No. US 2008/0147111 entitled “Endoluminal Filter with Fixation” filed Jun. 4, 2008 as U.S. patent application Ser. No. 11/969,827, (the “'7111 publication”) incorporated herein by reference in its entirety for all purposes. More particularly, the aspects of modifying a material capture structure to exhibit radio opaque, echogenic of combinations of radio opaque and echogenic characteristics may be applied to the various embodiments illustrated and described in FIGS. 30-34B, 38A-38B, 39-67, and 83-87. In one particular aspect, the filament/strand/suture 461 shown in FIG. 58 of the '7111 publication may be coated or doped as described above alone or in combination with the illustrated pharmacological coating 466.
In still another alternative aspect, any of the material capture structures in the '7111 publication may be combined with any of the filters illustrated and described in FIGS. 9-33. The material capture structures may be joined to the wires or other supports in the filters described herein to provide additional kinds of filtering capabilities in addition to or in place of the filtering capabilities of the filter so described.
In some embodiments, a pressure sensor and/or an intravascular ultrasound (IVUS) transducer can be added to or incorporated into a delivery system and method for use with any of the filters described herein. The pressure sensor can be used to measure the pressure at various positions within the vasculature, which can be used to determine blood flow, while the intravascular ultrasound (IVUS) transducer can be used to measure fluid flow and/or provide imaging within the vessel. These activities can be performed in cooperation with any of the filter embodiments described herein. In some embodiments, the pressure sensor and/or IVUS transducer can be incorporated into the guidewire at one or more locations, such as the distal end or distal portion of a guidewire, as described in U.S. Pat. Nos. 8,277,386, 6,106,476 and 6,780,157 which are hereby incorporated by reference in their entireties for all purposes, as well as being incorporated into intermediate and proximal portions of the guidewire. The guidewire with the pressure sensor and/or the IVUS transducer can be used much like a normal guidewire to help navigate the delivery device through the vasculature, with the added benefit of providing pressure measurements and ultrasound imaging to help in the navigation, to visualize the device placement site, and to monitor and ensure proper device deployment. In some embodiments, the IVUS transducer generates image slices as it is advanced and retracted which can then be assembled together to form a three dimensional reconstruction of the vasculature and/or the device within the vasculature. In some embodiments, the guidewire with the pressure sensor and/or IVUS transducer can be fastened to a catheter in a similar manner to that described below for a catheter having a pressure sensor and/or IVUS transducer that is fastened to another catheter.
In some embodiments, the pressure sensor and/or IVUS transducer can be located on a catheter in a similar configuration to the guidewire. For example, the IVUS transducer can be located on the distal tip of the catheter while the pressure sensor(s) can be located proximally of the IVUS transducer at one or more locations along the catheter body, from the distal portion of the catheter to an intermediate portion of the catheter to the proximal portion of the catheter. The pressure and/or imaging catheter can be used in parallel with the delivery or retrieval device or any other catheter that is inserted into the vasculature. In some embodiments, the pressure and/or imaging catheter can be fastened to the delivery or retrieval device or other catheter by, for example, enclosing both catheters in a sheath or larger catheter or by fusing the two catheters together. For example, U.S. Pat. Nos. 6,645,152 and 6,440,077, both to Jung et al. and hereby incorporated by reference in their entireties for all purposes, discloses an intravascular ultrasound catheter joined together in parallel with a vena cava filter delivery device to guide placement of the filter in the vena cava. The pressure and/or imaging catheter can be used for the same purposes as the pressure and/or imaging guidewire.
In some embodiments as illustrated in
Use of the ultrasound imaging system allows the operator to deliver the device without fluoroscopy or using less fluoroscopy, thereby reducing the radiation exposure to the patient, while allowing more accurate evaluation of the vasculature, aiding placement of the device and allowing confirmation that device placement was proper. The imaging can be used to aid in the deployment of the filters or other devices. The vasculature and implant location can be imaged prior to deployment, after deployment and/or during deployment. The imaging can be used to aid in positioning of the filter or device within the vasculature. The imaging can be used to image the deployment location and determine the appropriate sizing of the filter or other device. The imaging can be used to help estimate treatment duration.
Although an imaging systems described above have been ultrasound based, other imaging systems can be used instead or in addition. For example, the imaging system can be based on intravascular ultrasound (IVUS), Forward-Looking IVUS (FLIVUS), optical coherence tomography (OCT), piezoelectric micro-machined ultrasound traducer (PMUT), and FACT.
Additional aspects of the formation and use of echogenic materials is made with reference to the following US Patents and Patent Publications, each of which is incorporated herein by reference in its entirety: US 2010/0130963; U.S. Pat. Nos. 5,921,933; 4,276,885; 4,572,203; 4,718,433; 4,442,843; 5,327,891; 4,401,124; 4,265,251; 4,466,442; 4,718,433; 5,081,997; 5,289,831; and 5,201,314. Additional details of various filter designs described herein may be obtained with reference to the following U.S. Pat. Nos. 3,952,747; 4.817,600; 5,059,205; 5,242,462; 6,620,183; 6,217,600; 8,273,099; 4,494,531; 4,425,908; 4,832,055; 5,133,733; 3,540,431; 5,344,427; 5,725,550; 4,619,246; 4,990,156; 5,234,458; and 4,643,184, each of which is incorporated herein by reference in its entirety.
This application claims priority to U.S. Provisional Patent Application No. 61/785,204, filed Mar. 14, 2014, which is herein incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2014/027259 | 3/14/2014 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2014/152365 | 9/25/2014 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
152652 | Knowlton | Jun 1874 | A |
407971 | Siersdorfer | Jul 1889 | A |
621937 | Niemann | Mar 1899 | A |
796910 | Hernan | Aug 1905 | A |
1950378 | Andrews | Mar 1934 | A |
2163324 | Reinhold | Jun 1939 | A |
3301258 | Werner | Jan 1967 | A |
3540431 | Megin-Uddin | Nov 1970 | A |
3617880 | Cormack et al. | Nov 1971 | A |
3789841 | Antoshkiw | Feb 1974 | A |
3841308 | Tate | Oct 1974 | A |
3952747 | Kimmell | Apr 1976 | A |
4140364 | Yamashita et al. | Feb 1979 | A |
4265251 | Tickner | May 1981 | A |
4274423 | Mizuno et al. | Jun 1981 | A |
4276885 | Tickner et al. | Jul 1981 | A |
4344438 | Schultz | Aug 1982 | A |
4398791 | Dorsey | Aug 1983 | A |
4401124 | Guess et al. | Aug 1983 | A |
4425908 | Simon | Jan 1984 | A |
4432370 | Hughes et al. | Feb 1984 | A |
4442843 | Rasor et al. | Apr 1984 | A |
4466442 | Hilmann et al. | Aug 1984 | A |
4494531 | Gianturco | Jan 1985 | A |
4552554 | Gould et al. | Nov 1985 | A |
4572203 | Feinstein | Feb 1986 | A |
4577543 | Wilson | Mar 1986 | A |
4619246 | Molgaard-Nielsen et al. | Oct 1986 | A |
4643184 | Mobin-Uddin | Feb 1987 | A |
4676980 | Segal et al. | Jun 1987 | A |
4682895 | Costello | Jul 1987 | A |
4718433 | Feinstein | Jan 1988 | A |
4733665 | Palmaz | Mar 1988 | A |
4744619 | Cameron | May 1988 | A |
4762129 | Bonzel | Aug 1988 | A |
4766386 | Oliver et al. | Aug 1988 | A |
4771774 | Simpson et al. | Sep 1988 | A |
4794931 | Yock | Jan 1989 | A |
4800886 | Nestor | Jan 1989 | A |
4803639 | Steele et al. | Feb 1989 | A |
4816567 | Cabilly et al. | Mar 1989 | A |
4817600 | Herms et al. | Apr 1989 | A |
4819740 | Warrington | Apr 1989 | A |
4821731 | Martinelli et al. | Apr 1989 | A |
4824435 | Giesy et al. | Apr 1989 | A |
4830023 | de Toledo et al. | May 1989 | A |
4832055 | Palestrant | May 1989 | A |
4834093 | Littleford et al. | May 1989 | A |
4841977 | Griffith et al. | Jun 1989 | A |
4864578 | Proffitt et al. | Sep 1989 | A |
4873690 | Adams | Oct 1989 | A |
4877314 | Kanamori | Oct 1989 | A |
4887606 | Yock et al. | Dec 1989 | A |
4917085 | Smith | Apr 1990 | A |
4917097 | Proudian et al. | Apr 1990 | A |
4928693 | Goodin et al. | May 1990 | A |
4932413 | Shockey et al. | Jun 1990 | A |
4932419 | de Toledo | Jun 1990 | A |
4948229 | Soref | Aug 1990 | A |
4951677 | Crowley et al. | Aug 1990 | A |
4969742 | Falk et al. | Nov 1990 | A |
4987412 | Vaitekunas et al. | Jan 1991 | A |
4990156 | Lefebvre | Feb 1991 | A |
4993412 | Murphy-Chutorian | Feb 1991 | A |
4998972 | Chin et al. | Mar 1991 | A |
5000185 | Yock | Mar 1991 | A |
5024234 | Leary et al. | Jun 1991 | A |
5025445 | Anderson et al. | Jun 1991 | A |
5032123 | Katz et al. | Jul 1991 | A |
5037169 | Chun | Aug 1991 | A |
5039193 | Snow et al. | Aug 1991 | A |
5040548 | Yock | Aug 1991 | A |
5041108 | Fox et al. | Aug 1991 | A |
5054492 | Scribner et al. | Oct 1991 | A |
5059205 | El-Nounou et al. | Oct 1991 | A |
5065010 | Knute | Nov 1991 | A |
5065769 | de Toledo | Nov 1991 | A |
5081997 | Bosley et al. | Jan 1992 | A |
5085221 | Ingebrigtsen et al. | Feb 1992 | A |
5095911 | Pomeranz | Mar 1992 | A |
5098440 | Hillstead | Mar 1992 | A |
5100424 | Jang et al. | Mar 1992 | A |
5120308 | Hess | Jun 1992 | A |
5125137 | Corl et al. | Jun 1992 | A |
5133733 | Rasmussen et al. | Jul 1992 | A |
5135486 | Eberle et al. | Aug 1992 | A |
5135516 | Sahatjian et al. | Aug 1992 | A |
5155439 | Holmbo et al. | Oct 1992 | A |
5158548 | Lau et al. | Oct 1992 | A |
5163445 | Christian et al. | Nov 1992 | A |
5167233 | Eberle et al. | Dec 1992 | A |
5174295 | Christian et al. | Dec 1992 | A |
5176141 | Bom et al. | Jan 1993 | A |
5176674 | Hofmann | Jan 1993 | A |
5178159 | Christian | Jan 1993 | A |
5183048 | Eberle | Feb 1993 | A |
5188632 | Goldenberg | Feb 1993 | A |
5201314 | Bosley et al. | Apr 1993 | A |
5201316 | Pomeranz et al. | Apr 1993 | A |
5202745 | Sorin et al. | Apr 1993 | A |
5203779 | Muller et al. | Apr 1993 | A |
5220922 | Barany | Jun 1993 | A |
5224953 | Morgentaler | Jul 1993 | A |
5226421 | Frisbie et al. | Jul 1993 | A |
5234458 | Metais | Aug 1993 | A |
5240003 | Lancee et al. | Aug 1993 | A |
5240437 | Christian | Aug 1993 | A |
5242460 | Klein et al. | Sep 1993 | A |
5242462 | El-Nounou et al. | Sep 1993 | A |
5243988 | Sieben et al. | Sep 1993 | A |
5257974 | Cox | Nov 1993 | A |
5266302 | Peyman et al. | Nov 1993 | A |
5267954 | Nita | Dec 1993 | A |
5289831 | Bosley | Mar 1994 | A |
5301001 | Murphy et al. | Apr 1994 | A |
5312425 | Evans et al. | May 1994 | A |
5313949 | Yock | May 1994 | A |
5313957 | Little | May 1994 | A |
5319492 | Dorn et al. | Jun 1994 | A |
5321501 | Swanson et al. | Jun 1994 | A |
5325198 | Hartley et al. | Jun 1994 | A |
5327891 | Rammier | Jul 1994 | A |
5336178 | Kaplan et al. | Aug 1994 | A |
5344427 | Cottenceau et al. | Sep 1994 | A |
5346689 | Peyman et al. | Sep 1994 | A |
5348017 | Thornton et al. | Sep 1994 | A |
5348481 | Ortiz | Sep 1994 | A |
5353798 | Sieben | Oct 1994 | A |
5358409 | Obara | Oct 1994 | A |
5358478 | Thompson et al. | Oct 1994 | A |
5368037 | Eberle et al. | Nov 1994 | A |
5370657 | Irie | Dec 1994 | A |
5373845 | Gardineer et al. | Dec 1994 | A |
5373849 | Maroney et al. | Dec 1994 | A |
5375602 | Lancee et al. | Dec 1994 | A |
5375612 | Cottenceau et al. | Dec 1994 | A |
5377682 | Ueno et al. | Jan 1995 | A |
5383853 | Jung et al. | Jan 1995 | A |
5387193 | Miraki | Feb 1995 | A |
5396328 | Jestel et al. | Mar 1995 | A |
5397355 | Marin et al. | Mar 1995 | A |
5405377 | Cragg | Apr 1995 | A |
5411016 | Kume et al. | May 1995 | A |
5419777 | Hofling | May 1995 | A |
5421338 | Crowley et al. | Jun 1995 | A |
5423806 | Dale et al. | Jun 1995 | A |
5427118 | Nita et al. | Jun 1995 | A |
5431673 | Summers et al. | Jul 1995 | A |
5436759 | Dijaili et al. | Jul 1995 | A |
5439139 | Brovelli | Aug 1995 | A |
5443457 | Ginn et al. | Aug 1995 | A |
5453575 | O'Donnell et al. | Sep 1995 | A |
5456693 | Conston et al. | Oct 1995 | A |
5459570 | Swanson et al. | Oct 1995 | A |
5480388 | Zadini et al. | Jan 1996 | A |
5485845 | Verdonk et al. | Jan 1996 | A |
5492125 | Kim et al. | Feb 1996 | A |
5496997 | Pope | Mar 1996 | A |
5507761 | Duer | Apr 1996 | A |
5512044 | Duer | Apr 1996 | A |
5514128 | Hillsman et al. | May 1996 | A |
5529674 | Hedgcoth | Jun 1996 | A |
5541730 | Chaney | Jul 1996 | A |
5546717 | Penczak et al. | Aug 1996 | A |
5546948 | Hamm et al. | Aug 1996 | A |
5565332 | Hoogenboom et al. | Oct 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5581638 | Givens et al. | Dec 1996 | A |
5586054 | Jensen et al. | Dec 1996 | A |
5592939 | Martinelli | Jan 1997 | A |
5596079 | Smith et al. | Jan 1997 | A |
5598844 | Diaz et al. | Feb 1997 | A |
5601595 | Smith | Feb 1997 | A |
5609606 | O'Boyle | Mar 1997 | A |
5626605 | Irie et al. | May 1997 | A |
5630806 | Inagaki et al. | May 1997 | A |
5651366 | Liang et al. | Jul 1997 | A |
5660180 | Malinowski et al. | Aug 1997 | A |
5667499 | Welch et al. | Sep 1997 | A |
5667521 | Keown | Sep 1997 | A |
5672877 | Liebig et al. | Sep 1997 | A |
5674232 | Halliburton | Oct 1997 | A |
5693015 | Walker et al. | Dec 1997 | A |
5713848 | Dubrul et al. | Feb 1998 | A |
5725550 | Nadal | Mar 1998 | A |
5725552 | Kotula et al. | Mar 1998 | A |
5745634 | Garrett et al. | Apr 1998 | A |
5771895 | Slager | Jun 1998 | A |
5779731 | Leavitt | Jul 1998 | A |
5780958 | Strugach et al. | Jul 1998 | A |
5798521 | Froggatt | Aug 1998 | A |
5800450 | Lary et al. | Sep 1998 | A |
5803083 | Buck et al. | Sep 1998 | A |
5814061 | Osborne et al. | Sep 1998 | A |
5814064 | Daniel et al. | Sep 1998 | A |
5817025 | Alekseev et al. | Oct 1998 | A |
5820594 | Fontirroche et al. | Oct 1998 | A |
5824520 | Mulligan-Kehoe | Oct 1998 | A |
5827313 | Ream | Oct 1998 | A |
5830222 | Makower | Nov 1998 | A |
5848121 | Gupta et al. | Dec 1998 | A |
5851464 | Davila et al. | Dec 1998 | A |
5857974 | Eberle et al. | Jan 1999 | A |
5872829 | Wischmann et al. | Feb 1999 | A |
5873835 | Hastings et al. | Feb 1999 | A |
5882722 | Kydd | Mar 1999 | A |
5912764 | Togino | Jun 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5921931 | O'Donnell et al. | Jul 1999 | A |
5921933 | Sarkis et al. | Jul 1999 | A |
5925055 | Adrian et al. | Jul 1999 | A |
5925060 | Forber | Jul 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5949929 | Hamm | Sep 1999 | A |
5951586 | Berg et al. | Sep 1999 | A |
5974521 | Akerib | Oct 1999 | A |
5976120 | Chow et al. | Nov 1999 | A |
5978391 | Das et al. | Nov 1999 | A |
5997523 | Jang | Dec 1999 | A |
6021240 | Murphy et al. | Feb 2000 | A |
6022319 | Willard et al. | Feb 2000 | A |
6031071 | Mandeville et al. | Feb 2000 | A |
6036889 | Kydd | Mar 2000 | A |
6043883 | Leckel et al. | Mar 2000 | A |
6050949 | White et al. | Apr 2000 | A |
6053925 | Barnhart | Apr 2000 | A |
6059738 | Stoltze et al. | May 2000 | A |
6068638 | Makower | May 2000 | A |
6074362 | Jang et al. | Jun 2000 | A |
6078831 | Belef et al. | Jun 2000 | A |
6080109 | Baker et al. | Jun 2000 | A |
6080178 | Meglin | Jun 2000 | A |
6080182 | Shaw et al. | Jun 2000 | A |
6091496 | Hill | Jul 2000 | A |
6094591 | Foltz et al. | Jul 2000 | A |
6095976 | Nachtomy et al. | Aug 2000 | A |
6097755 | Guenther, Jr. et al. | Aug 2000 | A |
6099471 | Torp et al. | Aug 2000 | A |
6099549 | Bosma et al. | Aug 2000 | A |
6102938 | Evans et al. | Aug 2000 | A |
6106476 | Corl et al. | Aug 2000 | A |
6120445 | Grunwald | Sep 2000 | A |
6123673 | Eberle et al. | Sep 2000 | A |
6134003 | Tearney et al. | Oct 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6141089 | Thoma et al. | Oct 2000 | A |
6146328 | Chiao et al. | Nov 2000 | A |
6148095 | Prause et al. | Nov 2000 | A |
6151433 | Dower et al. | Nov 2000 | A |
6152877 | Masters | Nov 2000 | A |
6152878 | Nachtomy et al. | Nov 2000 | A |
6159225 | Makower | Dec 2000 | A |
6160084 | Langer et al. | Dec 2000 | A |
6165127 | Crowley | Dec 2000 | A |
6176842 | Tachibana et al. | Jan 2001 | B1 |
6179809 | Khairkhahan et al. | Jan 2001 | B1 |
6186949 | Hatfield et al. | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6200266 | Shokrollahi et al. | Mar 2001 | B1 |
6200268 | Vince et al. | Mar 2001 | B1 |
6203537 | Adrian | Mar 2001 | B1 |
6208415 | De Boer et al. | Mar 2001 | B1 |
6210332 | Chiao et al. | Apr 2001 | B1 |
6210339 | Kiepen et al. | Apr 2001 | B1 |
6212308 | Donald | Apr 2001 | B1 |
6217600 | Dimatteo | Apr 2001 | B1 |
6231518 | Grabek et al. | May 2001 | B1 |
6245066 | Morgan et al. | Jun 2001 | B1 |
6249076 | Madden et al. | Jun 2001 | B1 |
6254543 | Grunwald et al. | Jul 2001 | B1 |
6256090 | Chen et al. | Jul 2001 | B1 |
6258026 | Ravenscroft et al. | Jul 2001 | B1 |
6258052 | Milo | Jul 2001 | B1 |
6261246 | Pantages et al. | Jul 2001 | B1 |
6275628 | Jones et al. | Aug 2001 | B1 |
6283921 | Nix et al. | Sep 2001 | B1 |
6283951 | Flaherty et al. | Sep 2001 | B1 |
6295308 | Zah | Sep 2001 | B1 |
6299622 | Snow et al. | Oct 2001 | B1 |
6312384 | Chiao | Nov 2001 | B1 |
6325797 | Stewart et al. | Dec 2001 | B1 |
6328696 | Fraser | Dec 2001 | B1 |
6343168 | Murphy et al. | Jan 2002 | B1 |
6343178 | Burns et al. | Jan 2002 | B1 |
6350240 | Song et al. | Feb 2002 | B1 |
6364841 | White et al. | Apr 2002 | B1 |
6366722 | Murphy et al. | Apr 2002 | B1 |
6367984 | Stephenson et al. | Apr 2002 | B1 |
6373970 | Dong et al. | Apr 2002 | B1 |
6375615 | Flaherty et al. | Apr 2002 | B1 |
6375618 | Chiao et al. | Apr 2002 | B1 |
6375628 | Zadno-Azizi et al. | Apr 2002 | B1 |
6376830 | Froggatt et al. | Apr 2002 | B1 |
6379352 | Reynolds et al. | Apr 2002 | B1 |
6381350 | Klingensmith et al. | Apr 2002 | B1 |
6387124 | Buscemi et al. | May 2002 | B1 |
6388043 | Langer et al. | May 2002 | B1 |
6396976 | Little et al. | May 2002 | B1 |
6398792 | O'Connor | Jun 2002 | B1 |
6417948 | Chowdhury et al. | Jul 2002 | B1 |
6419644 | White et al. | Jul 2002 | B1 |
6421164 | Tearney et al. | Jul 2002 | B2 |
6423012 | Kato et al. | Jul 2002 | B1 |
6426796 | Pulliam et al. | Jul 2002 | B1 |
6428041 | Wohllebe et al. | Aug 2002 | B1 |
6428498 | Uflacker | Aug 2002 | B2 |
6429421 | Meller et al. | Aug 2002 | B1 |
6440077 | Jung et al. | Aug 2002 | B1 |
6443903 | White et al. | Sep 2002 | B1 |
6443972 | Bosma et al. | Sep 2002 | B1 |
6450964 | Webler | Sep 2002 | B1 |
6457365 | Stephens et al. | Oct 2002 | B1 |
6459844 | Pan | Oct 2002 | B1 |
6468290 | Weldon et al. | Oct 2002 | B1 |
6475149 | Sumanaweera | Nov 2002 | B1 |
6480285 | Hill | Nov 2002 | B1 |
6491631 | Chiao et al. | Dec 2002 | B2 |
6491636 | Chenal et al. | Dec 2002 | B2 |
6501551 | Tearney et al. | Dec 2002 | B1 |
6504286 | Porat et al. | Jan 2003 | B1 |
6508824 | Flaherty et al. | Jan 2003 | B1 |
6514237 | Maseda | Feb 2003 | B1 |
6514273 | Voss et al. | Feb 2003 | B1 |
6520269 | Geiger et al. | Feb 2003 | B2 |
6520677 | Iizuka | Feb 2003 | B2 |
6535764 | Imran et al. | Mar 2003 | B2 |
6538778 | Leckel et al. | Mar 2003 | B1 |
6544217 | Gulachenski | Apr 2003 | B1 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6544279 | Hopkins et al. | Apr 2003 | B1 |
6545760 | Froggatt et al. | Apr 2003 | B1 |
6546272 | MacKinnon et al. | Apr 2003 | B1 |
6551250 | Khalil | Apr 2003 | B2 |
6566648 | Froggatt | May 2003 | B1 |
6570894 | Anderson | May 2003 | B2 |
6572555 | White et al. | Jun 2003 | B2 |
6579311 | Makower | Jun 2003 | B1 |
6584335 | Haar et al. | Jun 2003 | B1 |
6592612 | Samson et al. | Jul 2003 | B1 |
6594448 | Herman et al. | Jul 2003 | B2 |
6602241 | Makower et al. | Aug 2003 | B2 |
6611322 | Nakayama et al. | Aug 2003 | B1 |
6611720 | Hata et al. | Aug 2003 | B2 |
6612992 | Hossack et al. | Sep 2003 | B1 |
6615062 | Ryan et al. | Sep 2003 | B2 |
6615072 | Izatt et al. | Sep 2003 | B1 |
6620183 | Dimatteo | Sep 2003 | B2 |
6621562 | Durston | Sep 2003 | B2 |
6631284 | Nutt et al. | Oct 2003 | B2 |
6638227 | Bae | Oct 2003 | B2 |
6645152 | Jung et al. | Nov 2003 | B1 |
6646745 | Verma et al. | Nov 2003 | B2 |
6655386 | Makower et al. | Dec 2003 | B1 |
6659957 | Vardi et al. | Dec 2003 | B1 |
6660024 | Flaherty et al. | Dec 2003 | B1 |
6663565 | Kawagishi et al. | Dec 2003 | B2 |
6665456 | Dave et al. | Dec 2003 | B2 |
6669716 | Gilson et al. | Dec 2003 | B1 |
6671055 | Wavering et al. | Dec 2003 | B1 |
6673015 | Glover et al. | Jan 2004 | B1 |
6673064 | Rentrop | Jan 2004 | B1 |
6685648 | Flaherty et al. | Feb 2004 | B2 |
6689056 | Kilcoyne et al. | Feb 2004 | B1 |
6689144 | Gerberding | Feb 2004 | B2 |
6696173 | Naundorf et al. | Feb 2004 | B1 |
6701044 | Arbore et al. | Mar 2004 | B2 |
6701176 | Halperin et al. | Mar 2004 | B1 |
6709444 | Makower | Mar 2004 | B1 |
6712836 | Berg et al. | Mar 2004 | B1 |
6714703 | Lee et al. | Mar 2004 | B2 |
6719717 | Johnson et al. | Apr 2004 | B1 |
6725073 | Motamedi et al. | Apr 2004 | B1 |
6726677 | Flaherty et al. | Apr 2004 | B1 |
6730107 | Kelley et al. | May 2004 | B2 |
6733474 | Kusleika | May 2004 | B2 |
6738144 | Dogariu | May 2004 | B1 |
6740113 | Vrba | May 2004 | B2 |
6746464 | Makower | Jun 2004 | B1 |
6780157 | Stephens et al. | Aug 2004 | B2 |
6795188 | Ruck et al. | Sep 2004 | B2 |
6795196 | Funakawa | Sep 2004 | B2 |
6798522 | Stolte et al. | Sep 2004 | B2 |
6822798 | Wu et al. | Nov 2004 | B2 |
6830559 | Schock | Dec 2004 | B2 |
6832024 | Gerstenberger et al. | Dec 2004 | B2 |
6842639 | Winston et al. | Jan 2005 | B1 |
6847449 | Bashkansky et al. | Jan 2005 | B2 |
6855115 | Fonseca et al. | Feb 2005 | B2 |
6856138 | Bohley | Feb 2005 | B2 |
6856400 | Froggatt | Feb 2005 | B1 |
6856472 | Herman et al. | Feb 2005 | B2 |
6860867 | Seward et al. | Mar 2005 | B2 |
6866670 | Rabiner et al. | Mar 2005 | B2 |
6878113 | Miwa et al. | Apr 2005 | B2 |
6886411 | Kjellman et al. | May 2005 | B2 |
6891984 | Petersen et al. | May 2005 | B2 |
6895106 | Wang et al. | May 2005 | B2 |
6898337 | Averett et al. | May 2005 | B2 |
6900897 | Froggatt | May 2005 | B2 |
6912051 | Jensen | Jun 2005 | B2 |
6916329 | Zhao | Jul 2005 | B1 |
6922498 | Shah | Jul 2005 | B2 |
6937346 | Nebendahl et al. | Aug 2005 | B2 |
6937696 | Mostafavi | Aug 2005 | B1 |
6943939 | DiJaili et al. | Sep 2005 | B1 |
6947147 | Motamedi et al. | Sep 2005 | B2 |
6947787 | Webler | Sep 2005 | B2 |
6949094 | Yaron | Sep 2005 | B2 |
6952603 | Gerber et al. | Oct 2005 | B2 |
6954737 | Kalantar et al. | Oct 2005 | B2 |
6958042 | Honda | Oct 2005 | B2 |
6961123 | Wang et al. | Nov 2005 | B1 |
6966891 | Ookubo et al. | Nov 2005 | B2 |
6969293 | Thai | Nov 2005 | B2 |
6969395 | Eskuri | Nov 2005 | B2 |
6985234 | Anderson | Jan 2006 | B2 |
7004963 | Wang et al. | Feb 2006 | B2 |
7006231 | Ostrovsky et al. | Feb 2006 | B2 |
7010458 | Wilt | Mar 2006 | B2 |
7024025 | Sathyanarayana | Apr 2006 | B2 |
7027211 | Ruffa | Apr 2006 | B1 |
7027743 | Tucker et al. | Apr 2006 | B1 |
7033347 | Appling | Apr 2006 | B2 |
7035484 | Silberberg et al. | Apr 2006 | B2 |
7037269 | Nix et al. | May 2006 | B2 |
7042573 | Froggatt | May 2006 | B2 |
7044915 | White et al. | May 2006 | B2 |
7044964 | Jang et al. | May 2006 | B2 |
7048711 | Rosenman et al. | May 2006 | B2 |
7049306 | Konradi et al. | May 2006 | B2 |
7058239 | Singh et al. | Jun 2006 | B2 |
7060033 | White et al. | Jun 2006 | B2 |
7060421 | Naundorf et al. | Jun 2006 | B2 |
7063679 | Maguire et al. | Jun 2006 | B2 |
7068852 | Braica | Jun 2006 | B2 |
7074188 | Nair et al. | Jul 2006 | B2 |
7095493 | Harres | Aug 2006 | B2 |
7110119 | Maestle | Sep 2006 | B2 |
7113875 | Terashima et al. | Sep 2006 | B2 |
7123777 | Rondinelli et al. | Oct 2006 | B2 |
7130054 | Ostrovsky et al. | Oct 2006 | B2 |
7139440 | Rondinelli et al. | Nov 2006 | B2 |
7153299 | Tu et al. | Dec 2006 | B1 |
7171078 | Sasaki et al. | Jan 2007 | B2 |
7175597 | Vince et al. | Feb 2007 | B2 |
7177491 | Dave et al. | Feb 2007 | B2 |
7190464 | Alphonse | Mar 2007 | B2 |
7215802 | Klingensmith et al. | May 2007 | B2 |
7218811 | Shigenaga et al. | May 2007 | B2 |
7236812 | Ballerstadt et al. | Jun 2007 | B1 |
7245125 | Harer et al. | Jul 2007 | B2 |
7245789 | Bates et al. | Jul 2007 | B2 |
7249357 | Landman et al. | Jul 2007 | B2 |
7291146 | Steinke et al. | Nov 2007 | B2 |
7292715 | Furnish | Nov 2007 | B2 |
7292885 | Scott et al. | Nov 2007 | B2 |
7294124 | Eidenschink | Nov 2007 | B2 |
7300460 | Levine et al. | Nov 2007 | B2 |
7335161 | Von Arx et al. | Feb 2008 | B2 |
7337079 | Park et al. | Feb 2008 | B2 |
7355716 | de Boer et al. | Apr 2008 | B2 |
7356367 | Liang et al. | Apr 2008 | B2 |
7358921 | Snyder et al. | Apr 2008 | B2 |
7359062 | Chen et al. | Apr 2008 | B2 |
7359554 | Klingensmith et al. | Apr 2008 | B2 |
7363927 | Ravikumar | Apr 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7382949 | Bouma et al. | Jun 2008 | B2 |
7387636 | Cohn et al. | Jun 2008 | B2 |
7391520 | Zhou et al. | Jun 2008 | B2 |
7397935 | Kimmel et al. | Jul 2008 | B2 |
7399095 | Rondinelli | Jul 2008 | B2 |
7408648 | Kleen et al. | Aug 2008 | B2 |
7414779 | Huber et al. | Aug 2008 | B2 |
7440087 | Froggatt et al. | Oct 2008 | B2 |
7447388 | Bates et al. | Nov 2008 | B2 |
7449821 | Dausch | Nov 2008 | B2 |
7450165 | Ahiska | Nov 2008 | B2 |
RE40608 | Glover et al. | Dec 2008 | E |
7458967 | Appling et al. | Dec 2008 | B2 |
7463362 | Lasker et al. | Dec 2008 | B2 |
7463759 | Klingensmith et al. | Dec 2008 | B2 |
7491226 | Palmaz et al. | Feb 2009 | B2 |
7515276 | Froggatt et al. | Apr 2009 | B2 |
7527594 | Vardi et al. | May 2009 | B2 |
7534251 | WasDyke | May 2009 | B2 |
7535797 | Peng et al. | May 2009 | B2 |
7547304 | Johnson | Jun 2009 | B2 |
7564949 | Sattler et al. | Jul 2009 | B2 |
7577471 | Camus et al. | Aug 2009 | B2 |
7583857 | Xu et al. | Sep 2009 | B2 |
7603165 | Townsend et al. | Oct 2009 | B2 |
7612773 | Magnin et al. | Nov 2009 | B2 |
7633627 | Choma et al. | Dec 2009 | B2 |
7645229 | Armstrong | Jan 2010 | B2 |
7658715 | Park et al. | Feb 2010 | B2 |
7660452 | Zwirn et al. | Feb 2010 | B2 |
7660492 | Bates et al. | Feb 2010 | B2 |
7666204 | Thornton et al. | Feb 2010 | B2 |
7672790 | McGraw et al. | Mar 2010 | B2 |
7680247 | Atzinger et al. | Mar 2010 | B2 |
7684991 | Stohr et al. | Mar 2010 | B2 |
7711413 | Feldman et al. | May 2010 | B2 |
7720322 | Prisco | May 2010 | B2 |
7728986 | Lasker et al. | Jun 2010 | B2 |
7734009 | Brunner et al. | Jun 2010 | B2 |
7736317 | Stephens et al. | Jun 2010 | B2 |
7742795 | Stone et al. | Jun 2010 | B2 |
7743189 | Brown et al. | Jun 2010 | B2 |
7762954 | Nix et al. | Jul 2010 | B2 |
7766896 | Kornkven Volk et al. | Aug 2010 | B2 |
7773792 | Kimmel et al. | Aug 2010 | B2 |
7775981 | Guracar et al. | Aug 2010 | B1 |
7777399 | Eidenschink et al. | Aug 2010 | B2 |
7781724 | Childers et al. | Aug 2010 | B2 |
7783337 | Feldman et al. | Aug 2010 | B2 |
7787127 | Galle et al. | Aug 2010 | B2 |
7789892 | Johnson et al. | Sep 2010 | B2 |
7792342 | Barbu et al. | Sep 2010 | B2 |
7801343 | Unal et al. | Sep 2010 | B2 |
7801590 | Feldman et al. | Sep 2010 | B2 |
7813609 | Petersen et al. | Oct 2010 | B2 |
7831081 | Li | Nov 2010 | B2 |
7846101 | Eberle et al. | Dec 2010 | B2 |
7853104 | Oota et al. | Dec 2010 | B2 |
7853316 | Milner et al. | Dec 2010 | B2 |
7854747 | Johnson et al. | Dec 2010 | B2 |
7860555 | Saadat | Dec 2010 | B2 |
7862508 | Davies et al. | Jan 2011 | B2 |
7872759 | Tearney et al. | Jan 2011 | B2 |
7880868 | Aoki | Feb 2011 | B2 |
7881763 | Brauker et al. | Feb 2011 | B2 |
7909844 | Alkhatib et al. | Mar 2011 | B2 |
7921854 | Hennings et al. | Apr 2011 | B2 |
7927784 | Simpson | Apr 2011 | B2 |
7929148 | Kemp | Apr 2011 | B2 |
7930014 | Huennekens et al. | Apr 2011 | B2 |
7930104 | Baker et al. | Apr 2011 | B2 |
7936462 | Jiang et al. | May 2011 | B2 |
7942852 | Mas et al. | May 2011 | B2 |
7947012 | Spurchise et al. | May 2011 | B2 |
7951186 | Eidenschink et al. | May 2011 | B2 |
7952719 | Brennan, III | May 2011 | B2 |
7972353 | Hendriksen et al. | Jul 2011 | B2 |
7976492 | Brauker et al. | Jul 2011 | B2 |
7977950 | Maslen | Jul 2011 | B2 |
7978916 | Klingensmith et al. | Jul 2011 | B2 |
7981041 | McGahan | Jul 2011 | B2 |
7981151 | Rowe | Jul 2011 | B2 |
7983737 | Feldman et al. | Jul 2011 | B2 |
7993333 | Oral et al. | Aug 2011 | B2 |
7995210 | Tearney et al. | Aug 2011 | B2 |
7996060 | Trofimov et al. | Aug 2011 | B2 |
7999938 | Wang | Aug 2011 | B2 |
8021377 | Eskuri | Sep 2011 | B2 |
8021420 | Dolan | Sep 2011 | B2 |
8036732 | Milner | Oct 2011 | B2 |
8040586 | Smith et al. | Oct 2011 | B2 |
8047996 | Goodnow et al. | Nov 2011 | B2 |
8049900 | Kemp et al. | Nov 2011 | B2 |
8050478 | Li et al. | Nov 2011 | B2 |
8050523 | Younge et al. | Nov 2011 | B2 |
8052605 | Muller et al. | Nov 2011 | B2 |
8057394 | Dala-Krishna | Nov 2011 | B2 |
8059923 | Bates et al. | Nov 2011 | B2 |
8070800 | Lock et al. | Dec 2011 | B2 |
8080800 | Hoctor et al. | Dec 2011 | B2 |
8088102 | Adams et al. | Jan 2012 | B2 |
8100838 | Wright et al. | Jan 2012 | B2 |
8104479 | Glynn et al. | Jan 2012 | B2 |
8108030 | Castella et al. | Jan 2012 | B2 |
8114102 | Galdonik et al. | Feb 2012 | B2 |
8116605 | Petersen et al. | Feb 2012 | B2 |
8125648 | Milner et al. | Feb 2012 | B2 |
8126239 | Sun et al. | Feb 2012 | B2 |
8133199 | Weber et al. | Mar 2012 | B2 |
8133269 | Flechsenhar et al. | Mar 2012 | B2 |
8140708 | Zaharia et al. | Mar 2012 | B2 |
8148877 | Jiang et al. | Apr 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8172757 | Jaffe et al. | May 2012 | B2 |
8177809 | Mavani et al. | May 2012 | B2 |
8187191 | Hancock et al. | May 2012 | B2 |
8187267 | Pappone et al. | May 2012 | B2 |
8187830 | Hu et al. | May 2012 | B2 |
8199218 | Lee et al. | Jun 2012 | B2 |
8206429 | Gregorich et al. | Jun 2012 | B2 |
8208995 | Tearney et al. | Jun 2012 | B2 |
8222906 | Wyar et al. | Jul 2012 | B2 |
8233681 | Aylward et al. | Jul 2012 | B2 |
8233718 | Klingensmith et al. | Jul 2012 | B2 |
8238624 | Doi et al. | Aug 2012 | B2 |
8239938 | Simeral et al. | Aug 2012 | B2 |
8273099 | Dimatteo | Sep 2012 | B2 |
8277386 | Ahmed et al. | Oct 2012 | B2 |
8280470 | Milner et al. | Oct 2012 | B2 |
8289284 | Glynn et al. | Oct 2012 | B2 |
8289522 | Tearney et al. | Oct 2012 | B2 |
8298147 | Huennekens et al. | Oct 2012 | B2 |
8298149 | Hastings et al. | Oct 2012 | B2 |
8301000 | Sillard et al. | Oct 2012 | B2 |
8309428 | Lemmerhirt et al. | Nov 2012 | B2 |
8317713 | Davies et al. | Nov 2012 | B2 |
8323201 | Towfiq et al. | Dec 2012 | B2 |
8329053 | Martin et al. | Dec 2012 | B2 |
8336643 | Harleman | Dec 2012 | B2 |
8349000 | Schreck | Jan 2013 | B2 |
8353945 | Andreas et al. | Jan 2013 | B2 |
8353954 | Cai et al. | Jan 2013 | B2 |
8357981 | Martin et al. | Jan 2013 | B2 |
8361097 | Patel et al. | Jan 2013 | B2 |
8386560 | Ma et al. | Feb 2013 | B2 |
8398591 | Mas et al. | Mar 2013 | B2 |
8412312 | Judell et al. | Apr 2013 | B2 |
8417491 | Trovato et al. | Apr 2013 | B2 |
8449465 | Nair et al. | May 2013 | B2 |
8454685 | Hariton et al. | Jun 2013 | B2 |
8454686 | Alkhatib | Jun 2013 | B2 |
8475522 | Jimenez et al. | Jul 2013 | B2 |
8478384 | Schmitt et al. | Jul 2013 | B2 |
8486062 | Belhe et al. | Jul 2013 | B2 |
8486063 | Werneth et al. | Jul 2013 | B2 |
8491567 | Magnin et al. | Jul 2013 | B2 |
8500798 | Rowe et al. | Aug 2013 | B2 |
8550911 | Sylla | Oct 2013 | B2 |
8594757 | Boppart et al. | Nov 2013 | B2 |
8597349 | Alkhatib | Dec 2013 | B2 |
8600477 | Beyar et al. | Dec 2013 | B2 |
8600917 | Schimert et al. | Dec 2013 | B1 |
8601056 | Lauwers et al. | Dec 2013 | B2 |
8620055 | Barratt et al. | Dec 2013 | B2 |
8644910 | Rousso et al. | Feb 2014 | B2 |
20010007940 | Tu et al. | Jul 2001 | A1 |
20010029337 | Pantages et al. | Oct 2001 | A1 |
20010037073 | White et al. | Nov 2001 | A1 |
20010046345 | Snyder et al. | Nov 2001 | A1 |
20010049548 | Vardi et al. | Dec 2001 | A1 |
20020034276 | Hu et al. | Mar 2002 | A1 |
20020041723 | Ronnekleiv et al. | Apr 2002 | A1 |
20020069676 | Kopp, II et al. | Jun 2002 | A1 |
20020089335 | Williams | Jul 2002 | A1 |
20020095171 | Belef | Jul 2002 | A1 |
20020099289 | Crowley | Jul 2002 | A1 |
20020163646 | Anderson | Nov 2002 | A1 |
20020186818 | Arnaud et al. | Dec 2002 | A1 |
20020193827 | McGuckin et al. | Dec 2002 | A1 |
20020196446 | Roth et al. | Dec 2002 | A1 |
20020197456 | Pope | Dec 2002 | A1 |
20030004412 | Izatt et al. | Jan 2003 | A1 |
20030016604 | Hanes | Jan 2003 | A1 |
20030018273 | Corl et al. | Jan 2003 | A1 |
20030023153 | Izatt et al. | Jan 2003 | A1 |
20030032886 | Dgany et al. | Feb 2003 | A1 |
20030050871 | Broughton | Mar 2003 | A1 |
20030065371 | Satake | Apr 2003 | A1 |
20030069723 | Hegde | Apr 2003 | A1 |
20030077043 | Hamm et al. | Apr 2003 | A1 |
20030085635 | Davidsen | May 2003 | A1 |
20030090753 | Takeyama et al. | May 2003 | A1 |
20030092995 | Thompson | May 2003 | A1 |
20030093059 | Griffin et al. | May 2003 | A1 |
20030103212 | Westphal et al. | Jun 2003 | A1 |
20030152259 | Belykh et al. | Aug 2003 | A1 |
20030171774 | Freudenthal et al. | Sep 2003 | A1 |
20030181802 | Ogawa | Sep 2003 | A1 |
20030187369 | Lewis et al. | Oct 2003 | A1 |
20030194165 | Silberberg et al. | Oct 2003 | A1 |
20030195419 | Harada | Oct 2003 | A1 |
20030208116 | Liang et al. | Nov 2003 | A1 |
20030212491 | Mitchell et al. | Nov 2003 | A1 |
20030219202 | Loeb et al. | Nov 2003 | A1 |
20030220749 | Chen et al. | Nov 2003 | A1 |
20030228039 | Green | Dec 2003 | A1 |
20040015065 | Panescu et al. | Jan 2004 | A1 |
20040023317 | Motamedi et al. | Feb 2004 | A1 |
20040028333 | Lomas | Feb 2004 | A1 |
20040037742 | Jen et al. | Feb 2004 | A1 |
20040042066 | Kinoshita et al. | Mar 2004 | A1 |
20040054287 | Stephens | Mar 2004 | A1 |
20040067000 | Bates et al. | Apr 2004 | A1 |
20040068161 | Couvillon | Apr 2004 | A1 |
20040082844 | Vardi et al. | Apr 2004 | A1 |
20040092830 | Scott et al. | May 2004 | A1 |
20040106853 | Moriyama | Jun 2004 | A1 |
20040111552 | Arimilli et al. | Jun 2004 | A1 |
20040126048 | Dave et al. | Jul 2004 | A1 |
20040143160 | Couvillon | Jul 2004 | A1 |
20040146546 | Gravett et al. | Jul 2004 | A1 |
20040186369 | Lam | Sep 2004 | A1 |
20040186512 | Bruckheimer et al. | Sep 2004 | A1 |
20040186558 | Pavcnik et al. | Sep 2004 | A1 |
20040195512 | Crosetto | Oct 2004 | A1 |
20040199201 | Kellett et al. | Oct 2004 | A1 |
20040220606 | Goshgarian | Nov 2004 | A1 |
20040225220 | Rich | Nov 2004 | A1 |
20040239938 | Izatt | Dec 2004 | A1 |
20040242990 | Brister et al. | Dec 2004 | A1 |
20040248439 | Gernhardt et al. | Dec 2004 | A1 |
20040260236 | Manning et al. | Dec 2004 | A1 |
20050013778 | Green et al. | Jan 2005 | A1 |
20050031176 | Hertel et al. | Feb 2005 | A1 |
20050036150 | Izatt et al. | Feb 2005 | A1 |
20050078317 | Law et al. | Apr 2005 | A1 |
20050101859 | Maschke | May 2005 | A1 |
20050140582 | Lee et al. | Jun 2005 | A1 |
20050140682 | Sumanaweera et al. | Jun 2005 | A1 |
20050140981 | Waelti | Jun 2005 | A1 |
20050140984 | Hitzenberger | Jun 2005 | A1 |
20050147303 | Zhou et al. | Jul 2005 | A1 |
20050165439 | Weber et al. | Jul 2005 | A1 |
20050171433 | Boppart et al. | Aug 2005 | A1 |
20050171438 | Chen et al. | Aug 2005 | A1 |
20050177185 | Becker et al. | Aug 2005 | A1 |
20050182297 | Gravenstein et al. | Aug 2005 | A1 |
20050196028 | Kleen et al. | Sep 2005 | A1 |
20050197585 | Brockway et al. | Sep 2005 | A1 |
20050213103 | Everett et al. | Sep 2005 | A1 |
20050215942 | Abrahamson et al. | Sep 2005 | A1 |
20050234445 | Conquergood et al. | Oct 2005 | A1 |
20050243322 | Lasker et al. | Nov 2005 | A1 |
20050249391 | Kimmel et al. | Nov 2005 | A1 |
20050251567 | Ballew et al. | Nov 2005 | A1 |
20050254059 | Alphonse | Nov 2005 | A1 |
20050264823 | Zhu et al. | Dec 2005 | A1 |
20060013523 | Childlers et al. | Jan 2006 | A1 |
20060015126 | Sher | Jan 2006 | A1 |
20060020285 | Niermann | Jan 2006 | A1 |
20060029634 | Berg et al. | Feb 2006 | A1 |
20060036167 | Shina | Feb 2006 | A1 |
20060038115 | Maas | Feb 2006 | A1 |
20060039004 | de Boer et al. | Feb 2006 | A1 |
20060041180 | Viswanathan et al. | Feb 2006 | A1 |
20060045536 | Arahira | Mar 2006 | A1 |
20060055936 | Yun et al. | Mar 2006 | A1 |
20060058622 | Tearney et al. | Mar 2006 | A1 |
20060064009 | Webler et al. | Mar 2006 | A1 |
20060067620 | Shishkov et al. | Mar 2006 | A1 |
20060069405 | Schaeffer | Mar 2006 | A1 |
20060072808 | Grimm et al. | Apr 2006 | A1 |
20060074442 | Noriega et al. | Apr 2006 | A1 |
20060098927 | Schmidt et al. | May 2006 | A1 |
20060100694 | Globerman | May 2006 | A1 |
20060106375 | Werneth et al. | May 2006 | A1 |
20060132790 | Gutin | Jun 2006 | A1 |
20060135870 | Webler | Jun 2006 | A1 |
20060142703 | Carter et al. | Jun 2006 | A1 |
20060142733 | Forsberg | Jun 2006 | A1 |
20060173299 | Romley et al. | Aug 2006 | A1 |
20060179255 | Yamazaki | Aug 2006 | A1 |
20060184048 | Saadat | Aug 2006 | A1 |
20060187537 | Huber et al. | Aug 2006 | A1 |
20060195269 | Yeatman et al. | Aug 2006 | A1 |
20060204119 | Feng et al. | Sep 2006 | A1 |
20060229591 | Lee | Oct 2006 | A1 |
20060239312 | Kewitsch et al. | Oct 2006 | A1 |
20060241342 | Macaulay et al. | Oct 2006 | A1 |
20060241465 | Huennekens et al. | Oct 2006 | A1 |
20060241503 | Schmitt et al. | Oct 2006 | A1 |
20060241675 | Johnson et al. | Oct 2006 | A1 |
20060244973 | Yun et al. | Nov 2006 | A1 |
20060258895 | Maschke | Nov 2006 | A1 |
20060264743 | Kleen et al. | Nov 2006 | A1 |
20060267756 | Kates | Nov 2006 | A1 |
20060270976 | Savage et al. | Nov 2006 | A1 |
20060276709 | Khamene et al. | Dec 2006 | A1 |
20060279742 | Tearney et al. | Dec 2006 | A1 |
20060279743 | Boesser et al. | Dec 2006 | A1 |
20060285638 | Boese et al. | Dec 2006 | A1 |
20060287595 | Maschke | Dec 2006 | A1 |
20060293597 | Johnson et al. | Dec 2006 | A1 |
20070015969 | Feldman et al. | Jan 2007 | A1 |
20070016029 | Donaldson et al. | Jan 2007 | A1 |
20070016034 | Donaldson | Jan 2007 | A1 |
20070016062 | Park et al. | Jan 2007 | A1 |
20070027390 | Maschke et al. | Feb 2007 | A1 |
20070036417 | Argiro et al. | Feb 2007 | A1 |
20070038061 | Huennekens et al. | Feb 2007 | A1 |
20070038121 | Feldman et al. | Feb 2007 | A1 |
20070038125 | Kleen et al. | Feb 2007 | A1 |
20070043292 | Camus et al. | Feb 2007 | A1 |
20070043597 | Donaldson | Feb 2007 | A1 |
20070049847 | Osborne | Mar 2007 | A1 |
20070060973 | Ludvig et al. | Mar 2007 | A1 |
20070065077 | Childers et al. | Mar 2007 | A1 |
20070066888 | Maschke | Mar 2007 | A1 |
20070066890 | Maschke | Mar 2007 | A1 |
20070066983 | Maschke | Mar 2007 | A1 |
20070084995 | Newton et al. | Apr 2007 | A1 |
20070100226 | Yankelevitz et al. | May 2007 | A1 |
20070135887 | Maschke | Jun 2007 | A1 |
20070142707 | Wiklof et al. | Jun 2007 | A1 |
20070156019 | Larkin et al. | Jul 2007 | A1 |
20070161893 | Milner et al. | Jul 2007 | A1 |
20070161896 | Adachi et al. | Jul 2007 | A1 |
20070161963 | Smalling | Jul 2007 | A1 |
20070162860 | Muralidharan et al. | Jul 2007 | A1 |
20070165141 | Srinivas et al. | Jul 2007 | A1 |
20070167710 | Unal et al. | Jul 2007 | A1 |
20070167804 | Park et al. | Jul 2007 | A1 |
20070191682 | Rolland et al. | Aug 2007 | A1 |
20070201736 | Klingensmith et al. | Aug 2007 | A1 |
20070206193 | Pesach | Sep 2007 | A1 |
20070208276 | Kornkven Volk et al. | Sep 2007 | A1 |
20070225220 | Ming et al. | Sep 2007 | A1 |
20070225590 | Ramos | Sep 2007 | A1 |
20070229801 | Tearney et al. | Oct 2007 | A1 |
20070232872 | Prough et al. | Oct 2007 | A1 |
20070232874 | Ince | Oct 2007 | A1 |
20070232890 | Hirota | Oct 2007 | A1 |
20070232891 | Hirota | Oct 2007 | A1 |
20070232892 | Hirota | Oct 2007 | A1 |
20070232893 | Tanioka | Oct 2007 | A1 |
20070232933 | Gille et al. | Oct 2007 | A1 |
20070238957 | Yared | Oct 2007 | A1 |
20070247033 | Eidenschink et al. | Oct 2007 | A1 |
20070250000 | Magnin et al. | Oct 2007 | A1 |
20070250036 | Volk et al. | Oct 2007 | A1 |
20070258094 | Izatt et al. | Nov 2007 | A1 |
20070260138 | Feldman et al. | Nov 2007 | A1 |
20070278389 | Ajgaonkar et al. | Dec 2007 | A1 |
20070287914 | Cohen | Dec 2007 | A1 |
20080002183 | Yatagai et al. | Jan 2008 | A1 |
20080013093 | Izatt et al. | Jan 2008 | A1 |
20080021275 | Tearney et al. | Jan 2008 | A1 |
20080027481 | Gilson et al. | Jan 2008 | A1 |
20080033534 | Cook et al. | Feb 2008 | A1 |
20080043024 | Schiwietz et al. | Feb 2008 | A1 |
20080045842 | Furnish | Feb 2008 | A1 |
20080051660 | Kakadaris et al. | Feb 2008 | A1 |
20080063304 | Russak et al. | Mar 2008 | A1 |
20080085041 | Breeuwer | Apr 2008 | A1 |
20080095465 | Mullick et al. | Apr 2008 | A1 |
20080095714 | Castella et al. | Apr 2008 | A1 |
20080097194 | Milner | Apr 2008 | A1 |
20080101667 | Begelman et al. | May 2008 | A1 |
20080108867 | Zhou | May 2008 | A1 |
20080114254 | Matcovitch et al. | May 2008 | A1 |
20080119739 | Vardi et al. | May 2008 | A1 |
20080124495 | Horn et al. | May 2008 | A1 |
20080125772 | Stone et al. | May 2008 | A1 |
20080139897 | Ainsworth et al. | Jun 2008 | A1 |
20080143707 | Mitchell | Jun 2008 | A1 |
20080146941 | Dala-Krishna | Jun 2008 | A1 |
20080147111 | Johnson | Jun 2008 | A1 |
20080154128 | Milner | Jun 2008 | A1 |
20080161696 | Schmitt et al. | Jul 2008 | A1 |
20080171944 | Brenneman et al. | Jul 2008 | A1 |
20080175465 | Jiang et al. | Jul 2008 | A1 |
20080177183 | Courtney et al. | Jul 2008 | A1 |
20080180683 | Kemp | Jul 2008 | A1 |
20080181477 | Izatt et al. | Jul 2008 | A1 |
20080187201 | Liang et al. | Aug 2008 | A1 |
20080228086 | Ilegbusi et al. | Sep 2008 | A1 |
20080247622 | Aylward et al. | Oct 2008 | A1 |
20080247716 | Thomas et al. | Oct 2008 | A1 |
20080262470 | Lee et al. | Oct 2008 | A1 |
20080262489 | Steinke | Oct 2008 | A1 |
20080269599 | Csavoy et al. | Oct 2008 | A1 |
20080281205 | Naghavi et al. | Nov 2008 | A1 |
20080281248 | Angheloiu et al. | Nov 2008 | A1 |
20080285043 | Fercher et al. | Nov 2008 | A1 |
20080287795 | Klingensmith et al. | Nov 2008 | A1 |
20080291463 | Milner et al. | Nov 2008 | A1 |
20080292173 | Hsieh et al. | Nov 2008 | A1 |
20080294034 | Krueger et al. | Nov 2008 | A1 |
20080298655 | Edwards | Dec 2008 | A1 |
20080306766 | Ozeki et al. | Dec 2008 | A1 |
20090009801 | Tabuki | Jan 2009 | A1 |
20090018393 | Dick et al. | Jan 2009 | A1 |
20090034813 | Dikmen et al. | Feb 2009 | A1 |
20090043191 | Castella et al. | Feb 2009 | A1 |
20090046295 | Kemp et al. | Feb 2009 | A1 |
20090052614 | Hempel et al. | Feb 2009 | A1 |
20090069843 | Agnew | Mar 2009 | A1 |
20090079993 | Yatagai et al. | Mar 2009 | A1 |
20090088650 | Corl | Apr 2009 | A1 |
20090093980 | Kemp et al. | Apr 2009 | A1 |
20090122320 | Petersen et al. | May 2009 | A1 |
20090138544 | Wegenkittl et al. | May 2009 | A1 |
20090149739 | Maschke | Jun 2009 | A9 |
20090156941 | Moore | Jun 2009 | A1 |
20090174886 | Inoue | Jul 2009 | A1 |
20090174931 | Huber et al. | Jul 2009 | A1 |
20090177090 | Grunwald et al. | Jul 2009 | A1 |
20090177183 | Pinkernell et al. | Jul 2009 | A1 |
20090195514 | Glynn et al. | Aug 2009 | A1 |
20090196470 | Carl et al. | Aug 2009 | A1 |
20090198125 | Nakabayashi et al. | Aug 2009 | A1 |
20090203991 | Papaioannou et al. | Aug 2009 | A1 |
20090264768 | Courtney et al. | Oct 2009 | A1 |
20090269014 | Winberg et al. | Oct 2009 | A1 |
20090270695 | McEowen | Oct 2009 | A1 |
20090284322 | Harrison et al. | Nov 2009 | A1 |
20090284332 | Moore et al. | Nov 2009 | A1 |
20090284749 | Johnson et al. | Nov 2009 | A1 |
20090290167 | Flanders et al. | Nov 2009 | A1 |
20090292048 | Li et al. | Nov 2009 | A1 |
20090299195 | Muller et al. | Dec 2009 | A1 |
20090299284 | Holman et al. | Dec 2009 | A1 |
20090318951 | Kashkarov et al. | Dec 2009 | A1 |
20090326634 | Vardi | Dec 2009 | A1 |
20100007669 | Bethune et al. | Jan 2010 | A1 |
20100030042 | Denninghoff et al. | Feb 2010 | A1 |
20100061611 | Xu et al. | Mar 2010 | A1 |
20100063400 | Hall et al. | Mar 2010 | A1 |
20100087732 | Eberle et al. | Apr 2010 | A1 |
20100094125 | Younge et al. | Apr 2010 | A1 |
20100094127 | Xu | Apr 2010 | A1 |
20100094135 | Fang-Yen et al. | Apr 2010 | A1 |
20100094143 | Mahapatra et al. | Apr 2010 | A1 |
20100113919 | Maschke | May 2010 | A1 |
20100125238 | Lye et al. | May 2010 | A1 |
20100125268 | Gustus et al. | May 2010 | A1 |
20100125648 | Zaharia et al. | May 2010 | A1 |
20100128348 | Taverner | May 2010 | A1 |
20100130963 | Ebert et al. | May 2010 | A1 |
20100152717 | Keeler | Jun 2010 | A1 |
20100160788 | Davies et al. | Jun 2010 | A1 |
20100161023 | Cohen et al. | Jun 2010 | A1 |
20100168714 | Burke et al. | Jul 2010 | A1 |
20100179421 | Tupin | Jul 2010 | A1 |
20100179426 | Davies et al. | Jul 2010 | A1 |
20100220334 | Condit et al. | Sep 2010 | A1 |
20100226607 | Zhang et al. | Sep 2010 | A1 |
20100234736 | Corl | Sep 2010 | A1 |
20100249601 | Courtney | Sep 2010 | A1 |
20100256616 | Katoh et al. | Oct 2010 | A1 |
20100268265 | Krolik et al. | Oct 2010 | A1 |
20100272432 | Johnson | Oct 2010 | A1 |
20100284590 | Peng et al. | Nov 2010 | A1 |
20100290693 | Cohen et al. | Nov 2010 | A1 |
20100331950 | Strommer | Dec 2010 | A1 |
20110010925 | Nix et al. | Jan 2011 | A1 |
20110021926 | Spencer et al. | Jan 2011 | A1 |
20110025853 | Richardson | Feb 2011 | A1 |
20110026797 | Declerck et al. | Feb 2011 | A1 |
20110032533 | Izatt et al. | Feb 2011 | A1 |
20110034801 | Baumgart | Feb 2011 | A1 |
20110034802 | Shrivastava | Feb 2011 | A1 |
20110044546 | Pan et al. | Feb 2011 | A1 |
20110066073 | Kuiper et al. | Mar 2011 | A1 |
20110071401 | Hastings et al. | Mar 2011 | A1 |
20110072405 | Chen et al. | Mar 2011 | A1 |
20110077528 | Kemp et al. | Mar 2011 | A1 |
20110080591 | Johnson et al. | Apr 2011 | A1 |
20110087104 | Moore et al. | Apr 2011 | A1 |
20110137140 | Tearney et al. | Jun 2011 | A1 |
20110144502 | Zhou et al. | Jun 2011 | A1 |
20110152771 | Milner et al. | Jun 2011 | A1 |
20110157597 | Lu et al. | Jun 2011 | A1 |
20110160586 | Li et al. | Jun 2011 | A1 |
20110178413 | Schmitt et al. | Jul 2011 | A1 |
20110190586 | Kemp | Aug 2011 | A1 |
20110216378 | Poon et al. | Sep 2011 | A1 |
20110220985 | Son et al. | Sep 2011 | A1 |
20110238061 | van der Weide et al. | Sep 2011 | A1 |
20110238083 | Moll et al. | Sep 2011 | A1 |
20110245669 | Zhang | Oct 2011 | A1 |
20110249094 | Wang et al. | Oct 2011 | A1 |
20110257545 | Suri | Oct 2011 | A1 |
20110264125 | Wilson et al. | Oct 2011 | A1 |
20110274329 | Mathew et al. | Nov 2011 | A1 |
20110282334 | Groenhoff | Nov 2011 | A1 |
20110301684 | Fischell et al. | Dec 2011 | A1 |
20110306995 | Moberg | Dec 2011 | A1 |
20110319752 | Steinberg et al. | Dec 2011 | A1 |
20120004529 | Tolkowsky et al. | Jan 2012 | A1 |
20120004668 | Wallace et al. | Jan 2012 | A1 |
20120013914 | Kemp et al. | Jan 2012 | A1 |
20120016344 | Kusakabe | Jan 2012 | A1 |
20120016395 | Olson | Jan 2012 | A1 |
20120022360 | Kemp | Jan 2012 | A1 |
20120022638 | Leewood et al. | Jan 2012 | A1 |
20120026503 | Lewandowski et al. | Feb 2012 | A1 |
20120029007 | Graham et al. | Feb 2012 | A1 |
20120059253 | Wang et al. | Mar 2012 | A1 |
20120059368 | Takaoka et al. | Mar 2012 | A1 |
20120062843 | Ferguson et al. | Mar 2012 | A1 |
20120065481 | Hunter et al. | Mar 2012 | A1 |
20120071823 | Chen | Mar 2012 | A1 |
20120071838 | Fojtik | Mar 2012 | A1 |
20120075638 | Rollins et al. | Mar 2012 | A1 |
20120083696 | Kitamura | Apr 2012 | A1 |
20120095340 | Smith | Apr 2012 | A1 |
20120095372 | Sverdlik et al. | Apr 2012 | A1 |
20120108943 | Bates et al. | May 2012 | A1 |
20120113108 | Dala-Krishna | May 2012 | A1 |
20120116353 | Arnold et al. | May 2012 | A1 |
20120130243 | Balocco et al. | May 2012 | A1 |
20120130247 | Waters et al. | May 2012 | A1 |
20120136259 | Milner et al. | May 2012 | A1 |
20120136427 | Palmaz et al. | May 2012 | A1 |
20120137075 | Vorbach | May 2012 | A1 |
20120155734 | Barratt et al. | Jun 2012 | A1 |
20120158101 | Stone et al. | Jun 2012 | A1 |
20120162660 | Kemp | Jun 2012 | A1 |
20120165661 | Kemp et al. | Jun 2012 | A1 |
20120170848 | Kemp et al. | Jul 2012 | A1 |
20120172698 | Teo et al. | Jul 2012 | A1 |
20120176607 | Ott | Jul 2012 | A1 |
20120184853 | Waters | Jul 2012 | A1 |
20120184859 | Shah et al. | Jul 2012 | A1 |
20120184977 | Wolf | Jul 2012 | A1 |
20120215094 | Rahimian et al. | Aug 2012 | A1 |
20120220836 | Alpert et al. | Aug 2012 | A1 |
20120220851 | Razansky et al. | Aug 2012 | A1 |
20120220865 | Brown et al. | Aug 2012 | A1 |
20120220874 | Hancock et al. | Aug 2012 | A1 |
20120220883 | Manstrom et al. | Aug 2012 | A1 |
20120224751 | Kemp et al. | Sep 2012 | A1 |
20120226153 | Brown et al. | Sep 2012 | A1 |
20120230565 | Steinberg et al. | Sep 2012 | A1 |
20120232400 | Dickinson et al. | Sep 2012 | A1 |
20120238869 | Schmitt et al. | Sep 2012 | A1 |
20120238956 | Yamada et al. | Sep 2012 | A1 |
20120244043 | Leblanc et al. | Sep 2012 | A1 |
20120250028 | Schmitt et al. | Oct 2012 | A1 |
20120253186 | Simpson et al. | Oct 2012 | A1 |
20120253192 | Cressman | Oct 2012 | A1 |
20120253276 | Govari et al. | Oct 2012 | A1 |
20120257210 | Whitney et al. | Oct 2012 | A1 |
20120262720 | Brown et al. | Oct 2012 | A1 |
20120265077 | Gille et al. | Oct 2012 | A1 |
20120265268 | Blum et al. | Oct 2012 | A1 |
20120265296 | McNamara et al. | Oct 2012 | A1 |
20120271170 | Emelianov et al. | Oct 2012 | A1 |
20120271175 | Moore et al. | Oct 2012 | A1 |
20120271339 | O'Beirne et al. | Oct 2012 | A1 |
20120274338 | Baks et al. | Nov 2012 | A1 |
20120276390 | Ji et al. | Nov 2012 | A1 |
20120277722 | Gerber et al. | Nov 2012 | A1 |
20120279764 | Jiang et al. | Nov 2012 | A1 |
20120283758 | Miller et al. | Nov 2012 | A1 |
20120289987 | Wilson et al. | Nov 2012 | A1 |
20120299439 | Huang | Nov 2012 | A1 |
20120310081 | Adler et al. | Dec 2012 | A1 |
20120310332 | Murray et al. | Dec 2012 | A1 |
20120319535 | Dausch | Dec 2012 | A1 |
20120323075 | Younge et al. | Dec 2012 | A1 |
20120323127 | Boyden et al. | Dec 2012 | A1 |
20120330141 | Brown et al. | Dec 2012 | A1 |
20130012981 | Johnson et al. | Jan 2013 | A1 |
20130015975 | Huennekens et al. | Jan 2013 | A1 |
20130023762 | Huennekens et al. | Jan 2013 | A1 |
20130023763 | Huennekens et al. | Jan 2013 | A1 |
20130023981 | Dierking et al. | Jan 2013 | A1 |
20130026655 | Lee et al. | Jan 2013 | A1 |
20130030295 | Huennekens et al. | Jan 2013 | A1 |
20130030303 | Ahmed et al. | Jan 2013 | A1 |
20130030410 | Drasler et al. | Jan 2013 | A1 |
20130053949 | Pintor et al. | Feb 2013 | A1 |
20130109958 | Baumgart et al. | May 2013 | A1 |
20130109959 | Baumgart et al. | May 2013 | A1 |
20130137980 | Waters et al. | May 2013 | A1 |
20130150716 | Stigall et al. | Jun 2013 | A1 |
20130158594 | Carrison et al. | Jun 2013 | A1 |
20130218201 | Obermiller et al. | Aug 2013 | A1 |
20130218267 | Braido et al. | Aug 2013 | A1 |
20130223789 | Lee et al. | Aug 2013 | A1 |
20130223798 | Jenner et al. | Aug 2013 | A1 |
20130289519 | Johnson et al. | Oct 2013 | A1 |
20130289610 | Johnson et al. | Oct 2013 | A1 |
20130296704 | Magnin et al. | Nov 2013 | A1 |
20130303907 | Corl | Nov 2013 | A1 |
20130303920 | Corl | Nov 2013 | A1 |
20130310698 | Judell et al. | Nov 2013 | A1 |
20130331820 | Itou et al. | Dec 2013 | A1 |
20130338766 | Hastings et al. | Dec 2013 | A1 |
20130339958 | Droste et al. | Dec 2013 | A1 |
20140039294 | Jiang | Feb 2014 | A1 |
20140180067 | Stigall et al. | Jun 2014 | A1 |
20140180128 | Corl | Jun 2014 | A1 |
20140200438 | Millett et al. | Jul 2014 | A1 |
20150164630 | Johnson et al. | Jun 2015 | A1 |
20150173830 | Johnson et al. | Jun 2015 | A1 |
20150173884 | Johnson et al. | Jun 2015 | A1 |
20150173924 | Johnson et al. | Jun 2015 | A1 |
20160030151 | Johnson et al. | Feb 2016 | A1 |
20160030152 | Johnson et al. | Feb 2016 | A1 |
Number | Date | Country |
---|---|---|
2635045 | Aug 2004 | CN |
101965161 | Feb 2011 | CN |
1041373 | Oct 2000 | EP |
01172637 | Jan 2002 | EP |
2438877 | Apr 2012 | EP |
1588072 | Apr 1981 | GB |
2280261 | Jan 1995 | GB |
2000-262461 | Sep 2000 | JP |
2000-292260 | Oct 2000 | JP |
2001-125009 | May 2001 | JP |
2001-272331 | Oct 2001 | JP |
2002-374034 | Dec 2002 | JP |
2003-143783 | May 2003 | JP |
2003-172690 | Jun 2003 | JP |
2003-256876 | Sep 2003 | JP |
2003-287534 | Oct 2003 | JP |
2005-274380 | Oct 2005 | JP |
2006-184284 | Jul 2006 | JP |
2006-266797 | Oct 2006 | JP |
2006-313158 | Nov 2006 | JP |
2007-024677 | Feb 2007 | JP |
2009-233001 | Oct 2009 | JP |
2011-56786 | Mar 2011 | JP |
9101156 | Feb 1991 | WO |
9216865 | Oct 1992 | WO |
9306213 | Apr 1993 | WO |
9308829 | May 1993 | WO |
9838907 | Sep 1998 | WO |
9857583 | Dec 1998 | WO |
0011511 | Mar 2000 | WO |
00044296 | Aug 2000 | WO |
0111409 | Feb 2001 | WO |
03062802 | Jul 2003 | WO |
03073950 | Sep 2003 | WO |
2004010856 | Feb 2004 | WO |
2004023992 | Mar 2004 | WO |
2004096049 | Nov 2004 | WO |
2005047813 | May 2005 | WO |
2005106695 | May 2005 | WO |
2005102211 | Nov 2005 | WO |
2005102211 | Nov 2005 | WO |
2006029634 | Mar 2006 | WO |
2006034233 | Mar 2006 | WO |
2006037132 | Apr 2006 | WO |
2006039091 | Apr 2006 | WO |
2006061829 | Jun 2006 | WO |
2006068875 | Jun 2006 | WO |
2006111704 | Oct 2006 | WO |
2006119416 | Nov 2006 | WO |
2006121851 | Nov 2006 | WO |
2006130802 | Dec 2006 | WO |
2007002685 | Jan 2007 | WO |
2007025230 | Mar 2007 | WO |
2007045690 | Apr 2007 | WO |
2007058895 | May 2007 | WO |
2007067323 | Jun 2007 | WO |
2007084995 | Jul 2007 | WO |
2008058084 | May 2008 | WO |
2008069991 | Jun 2008 | WO |
2008107905 | Sep 2008 | WO |
2008127983 | Oct 2008 | WO |
2009009799 | Jan 2009 | WO |
2009009801 | Jan 2009 | WO |
2009046431 | Apr 2009 | WO |
2009121067 | Oct 2009 | WO |
2009137704 | Nov 2009 | WO |
2014144362 | Dec 2010 | WO |
201106886 | Jan 2011 | WO |
2011038048 | Mar 2011 | WO |
2011081688 | Jul 2011 | WO |
2012003369 | Jan 2012 | WO |
2012003369 | Jan 2012 | WO |
2012061935 | May 2012 | WO |
2012071388 | May 2012 | WO |
2012087818 | Jun 2012 | WO |
2012098194 | Jul 2012 | WO |
2012109676 | Aug 2012 | WO |
2012130289 | Oct 2012 | WO |
2012154767 | Nov 2012 | WO |
2012155040 | Nov 2012 | WO |
2013033414 | Mar 2013 | WO |
2013033415 | Mar 2013 | WO |
2013033418 | Mar 2013 | WO |
2013033489 | Mar 2013 | WO |
2013033490 | Mar 2013 | WO |
2013033592 | Mar 2013 | WO |
2013126390 | Aug 2013 | WO |
2014109879 | Jul 2014 | WO |
Entry |
---|
Sihan et al., 2008, A novel approach to quantitative analysis of intraluminal optical coherence tomography imaging, Comput. Cardiol:1089-1092. |
Siwy et al., 2003, Electro-responsive asymmetric nanopores in polyimide with stable ion-current signal, Applied Physics A: Materials Science & Processing 76:781-785. |
Smith et al., 1989, Absolute displacement measurements using modulation of the spectrum of white light in a Michelson interferometer, Applied Optics, 28(16):3339-3342. |
Smith, 1997, The Scientist and Engineer's Guide to Digital Signal Processing, California Technical Publishing, San Diego, CA:432-436. |
Soller, 2003, Polarization diverse optical frequency domain interferometry:All coupler implementation, Bragg Grating, Photosensitivity, and Poling in Glass Waveguides Conference MB4:30-32. |
Song et al., 2012, Active tremor cancellation by a “Smart” handheld vitreoretinal microsurgical tool using swept source optical coherence tomography, Optics Express, 20(21):23414-23421. |
Stenqvist et al., 1983, Stiffness of central venous catheters, Acta Anaesthesiol Scand., 2:153-157. |
Strickland, 1970, Time-Domain Reflectometer Measurements, Tektronix, Beaverton, OR, (107 pages). |
Strobl et al., 2009, An Introduction to Recursive Partitioning:Rationale, Application and Characteristics of Classification and Regression Trees, Bagging and Random Forests, Psychol Methods., 14(4):323-348. |
Sutcliffe et al., 1986, Dynamics of UV laser ablation of organic polymer surfaces, Journal of Applied Physics, 60(9):3315-3322. |
Suzuki, 2013, A novel guidewire approach for handling acute-angle bifurcations, J Inv Cardiol 25(1):48-54. |
Tanimoto et al., 2008, A novel approach for quantitative analysis of intracoronary optical coherence tomography: high inter-observer agreement with computer-assisted contour detection, Cathet Cardiovascular Intervent., 72(2):228-235. |
Tearney et al., 1997, In vivo Endoscopic Optical Biopsy with Optical Coherence Tomography, Science, 276:2037-2039. |
Tonino et al., 2009, Fractional flow reserve versus angiography for guiding percutaneous coronary intervention, The New England Journal of Medicine, 360:213-224. |
Toregeani et al., 2008, Evaluation of hemodialysis arteriovenous fistula maturation by color-flow Doppler ultrasound, J Vasc. Bras. 7(3):203-213. |
Translation of Notice of Reason(s) for Refusal dated Apr. 30, 2014, for Japanese Patent Application No. 2011-508677, (5 pages). |
Translation of Notice of Reason(s) for Refusal dated May 25, 2012, for Japanese Patent Application No. 2009-536425, (3 pages). |
Translation of Notice of Reason(s) for Refusal dated Nov. 22, 2012, for Japanese Patent Application No. 2010-516304, (6 pages). |
Traunecker et al., 1991, Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells, EMBO J., 10:3655-3659. |
Trolier-McKinstry et. al., 2004, Thin Film Piezoelectric for MEMS, Journal of Electroceramics 12:7-17. |
Tuniz et al., 2010, Weaving the invisible thread: design of an optically invisible metamaterial fibre, Optics Express 18(17)18095-18105. |
Turk et al., 1991, Eigenfaces for Recognition, Journal of Cognitive Neuroscience 3(1):71-86. |
Tuzel et al., 2006, Region Covariance: A Fast Descriptor for Detection and Classification, European Conference on Computer Vision (ECCV). |
Urban et al., 2010, Design of a Pressure Sensor Based on Optical Bragg Grating Lateral Deformation, Sensors (Basel), 10(12):11212-11225. |
Vakhtin et al., 2003, Common-path interferometer for frequency-domain optical coherence tomography, Applied Optics, 42(34):6953-6958. |
Vakoc et al., 2005, Phase-Resolved Optical Frequency Domain Imaging, Optics Express 13(14):5483-5493. |
Verhoeyen et al., 1988, Reshaping human antibodies: grafting an antilysozyme activity, Science, 239:1534-1536. |
Villard et al., 2002, Use of a blood substitute to determine instantaneous murine right ventricular thickening with optical coherence tomography, Circulation, 105:1843-1849. |
Wang et al., 2002, Optimizing the Beam Patten of a Forward-Viewing Ring-Annular Ultrasound Array for Intravascular Imaging, Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 49(12). |
Wang et al., 2006, Multiple biomarkers for the prediction of first major cardiovascular events and death, The New England Journal of Medicine, 355(25):2631-2639. |
Wang et al., 2009, Robust Guidewire Tracking in Fluoroscopy, IEEE Conference on Computer Vision and Pattern Recognition—CVPR 2009:691-698. |
Wang et al., 2011, In vivo intracardiac optical coherence tomography imaging through percutaneous access: toward image-guided radio-frequency ablation, J. Biomed. Opt. 0001 16(11):110505-1 (3 pages). |
Waterhouse et. al., 1993, Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires, Nucleic Acids Res., 21:2265-2266. |
Wegener, 2011, 3D Photonic Metamaterials and Invisibility Cloaks: The Method of Making, MEMS 2011, Cancun, Mexico, Jan. 23-27, 2011. |
West et al., 1991, Arterial insufficiency in hemodialysis access procedures: correction by banding technique, Transpl Proc 23(2):1838-40. |
Wyawahare et al., 2009, Image registration techniques: an overview, International Journal of Signal Processing, Image Processing and Pattern Recognition, 2(3):11-28. |
Yaqoob et al., 2006, Methods and application areas of endoscopic optical coherence tomography, J. Biomed. Opt., 11, 063001-1-063001-19. |
Yasuno et al., 2004, Polarization-sensitive complex Fourier domain optical coherence tomography for Jones matrix imaging of biological samples, Applied Physics Letters 85(15):3023-3025. |
Zhang et al., 2004, Full range polarization-sensitive Fourier domain optical coherence tomography, Optics Express, 12(24):6033-6039. |
Zitova et al., 2003, Image registration methods: A survey. Image and Vision Computing, 21(11):977-1000. |
Kinney TB, Update on inferior vena cava filters, JVIR 2003; 14:425-440. |
DeWeese MS, A vena cava filter for prevention of pulmonary embolism, Arch of Surg 1963; 86:852-868, incorporate herein by reference. |
International Search Report and Written Opinion dated Nov. 2, 2012, for International Patent Application No. PCT/US12/53168, filed Aug. 30, 2013 (8 pages). |
International Search Report and Written Opinion dated Apr. 14, 2014, for International Patent Application No. PCT/US2013/076148, filed Dec. 18, 2013 (8 pages). |
International Search Report and Written Opinion dated Apr. 21, 2014, for International Patent Application No. PCT/US2013/076015, filed Dec. 18, 2013 (7 pages). |
International Search Report and Written Opinion dated Apr. 23, 2014, for International Patent Application No. PCT/US2013/075328, filed Dec. 16, 2013 (8 pages). |
International Search Report and Written Opinion dated Apr. 29, 2014, for International Patent Application No. PCT/US13/76093, filed Dec. 18, 2013 (6 pages). |
International Search Report and Written Opinion dated Apr. 9, 2014, for International Patent Application No. PCT/US13/75089, filed Dec. 13, 2013 (7 pages). |
International Search Report and Written Opinion dated Feb. 21, 2014, for International Patent Application No. PCT/US13/76053, filed Dec. 18, 2013 (9 pages). |
International Search Report and Written Opinion dated Feb. 21, 2014, for International Patent Application No. PCT/US2013/076965, filed Dec. 20, 2013 (6 pages). |
International Search Report and Written Opinion dated Feb. 27, 2014, for International Patent Application No. PCT/US13/75416, filed Dec. 16, 2013 (7 pages). |
International Search Report and Written Opinion dated Feb. 28, 2014, for International Patent Application No. PCT/US13/75653, filed Dec. 17, 2013 (7 pages). |
International Search Report and Written Opinion dated Feb. 28, 2014, for International Patent Application No. PCT/US13/75990, filed Dec. 18, 2013 (7 pages). |
International Search Report and Written Opinion dated Jan. 16, 2009, for International Patent Application No. PCT/US08/78963 filed on Oct. 6, 2008 (7 Pages). |
International Search Report and Written Opinion dated Jul. 30, 2014, for International Patent Application No. PCT/US14/21659, filed Mar. 7, 2014 (15 pages). |
International Search Report and Written Opinion dated Mar. 10, 2014, for International Patent Application No. PCT/US2013/076212, filed Dec. 18, 2013 (8 pages). |
International Search Report and Written Opinion dated Mar. 11, 2014, for International Patent Application No. PCT/US13/76173, filed Dec. 16, 2013 (9 pages). |
International Search Report and Written Opinion dated Mar. 11, 2014, for International Patent Application No. PCT/US13/76449, filed Dec. 19, 2013 (9 pages). |
International Search Report and Written Opinion dated Mar. 18, 2014, for International Patent Application No. PCT/US2013/076502, filed Dec. 19, 2013 (7 pages). |
International Search Report and Written Opinion dated Mar. 18, 2014, for International Patent Application No. PCT/US2013/076788, filed Dec. 20, 2013 (7 pages). |
International Search Report and Written Opinion dated Mar. 19, 2014, for International Patent Application No. PCT/US13/75349, filed Dec. 16, 2013 (10 pages). |
International Search Report and Written Opinion dated Mar. 19, 2014, for International Patent Application No. PCT/US2013/076587, filed Dec. 19, 2013 (10 pages). |
International Search Report and Written Opinion dated Mar. 19, 2014, for International Patent Application No. PCT/US2013/076909, filed Dec. 20, 2013 (7 pages). |
International Search Report and Written Opinion dated Mar. 7, 2014, for International Patent Application No. PCT/US2013/076304, filed Dec. 18, 2013 (9 pages). |
International Search Report and Written Opinion dated Mar. 7, 2014, for International Patent Application No. PCT/US2013/076480, filed Dec. 19, 2013 (8 pages). |
International Search Report and Written Opinion dated Mar. 7, 2014, for International Patent Application No. PCT/US2013/076512, filed Dec. 19, 2013 (8 pages). |
International Search Report and Written Opinion dated Mar. 7, 2014, for International Patent Application No. PCT/US2013/076531, filed Dec. 19, 2013 (10 pages). |
Jakobovits et al., 1993, Analysis of homozygous mutant chimeric mice:deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production, PNAS USA 90:2551-255. |
Jakobovits et al., 1993, Germ-line transmission and expression of a human-derived yeast artificial chromosome, Nature 362:255-258. |
Jang et al., 2002, Visualization of Coronary Atherosclerotic Plaques in Patients Using Optical Coherence Tomography: Comparison With Intravascular Ultrasound, Journal of the American College of Cardiology 39:604-609. |
Jiang et al., 1992, Image registration of multimodality 3-D medical images by chamfer matching, Proc. SPIE 1660, Biomedical Image Processing and Three-Dimensional Microscopy, 356-366. |
Johnson et al., 1993, Human antibody engineering: Current Opinion in Structural Biology, 3:564-571. |
Jones et al., 1986, Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature, 321:522-525. |
Juviler et al., 2008, Anorectal sepsis and fistula-in-ano, Surgical Technology International, 17:139-149. |
Karapatis et al., 1998, Direct rapid tooling:a review of current research, Rapid Prototyping Journal, 4(2):77-89. |
Karp et al., 2009, The benefit of time-of-flight in PET imaging, J Nucl Med 49:462-470. |
Kelly et al., 2005, Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle, Circulation Research 96:327-336. |
Kemp et al., 2005, Depth Resolved Optic Axis Orientation in Multiple Layered Anisotropic Tissues Measured with Enhanced Polarization Sensitive Optical Coherence Tomography, Optics Express 13(12):4507-4518. |
Kersey et al., 1991, Polarization insensitive fiber optic Michelson interferometer, Electron. Lett. 27:518-520. |
Kheir et al., 2012, Oxygen Gas-Filled Microparticles Provide Intravenous Oxygen Delivery, Science Translational Medicine 4(140):140ra88 (10 pages). |
Khuri-Yakub et al., 2011, Capacitive micromachined ultrasonic transducers for medical imaging and therapy, J Micromech Microeng. 21(5):054004-054014. |
Kirkman, 1991, Technique for flow reduction in dialysis access fistulas, Surg Gyn Obstet, 172(3):231-3. |
Kohler et al., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 256:495-7. |
Koo et al., 2011, Diagnosis of IschemiaCausing Coronary Stenoses by Noninvasive Fractional Flow Reserve Computed From Coronary Computed Tomographic Angiograms, J Am Coll Cardiol 58(19):1989-1997. |
Kozbor et al., 1984, A human hybrid myeloma for production of human monoclonal antibodies, J. Immunol., 133:3001-3005. |
Kruth et al., 2003, Lasers and materials in selective laser sintering, Assembly Automation, 23(4):357-371. |
Kumagai et al., 1994, Ablation of polymer films by a femtosecond high-peak-power Ti:sapphire laser at 798 nm, Applied Physics Letters, 65(14):1850-1852. |
Larin et al., 2002, Noninvasive Blood Glucose Monitoring with Optical Coherence Tomography: a pilot study in human subjects, Diabetes Care, 25(12):2263-7. |
Larin et al., 2004, Measurement of Refractive Index Variation of Physiological Analytes using Differential Phase OCT, Proc of SPIE 5325:31-34. |
Laufer, 1996, Introduction to Optics and Lasers in Engineering, Cambridge University Press, Cambridge UK:156-162. |
Lefevre et al., 2001, Stenting of bifurcation lesions:a rational approach, J. Interv. Cardiol., 14(6):573-585. |
Li et al., 2000, Optical Coherence Tomography: Advanced Technology for the Endoscopic Imaging of Barrett's Esophagus, Endoscopy, 32(12):921-930. |
Little et al., 1991, The underlying coronary lesion in myocardial infarction:implications for coronary angiography, Clinical Cardiology, 14(11):868-874. |
Loo, 2004, Nanoshell Enabled Photonics-Based Imaging and Therapy of Cancer, Technology in Cancer Research & Treatment 3(1):33-40. |
Machine translation of JP 2000-097846, Published Oct. 10, 2001. |
Machine translation of JP 2000-321034, Sep. 5, 2002. |
Machine translation of JP 2000-329534, Published Oct. 5, 2002. |
Machine translation of JP 2004-004080, Published Aug. 1, 2004. |
Maintz et al., 1998, An Overview of Medical Image Registration Methods, Technical Report UU-CS, (22 pages). |
Mamas et al., 2010, Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve, Journal of Invasive Cardiology 22(6):260-265. |
Marks et al., 1991, By-passing Immunization Human Antibodies from V-gene Libraries Displayed on Phage, J. Mol. Biol. 222:581-597. |
Marks et al., 1992, By-Passing Immunization:Building High Affinity Human Antibodies by Chain Shuffling, BioTechnol., 10:779-783. |
Maruno et al., 1991, Fluorine containing optical adhesives for optical communications systems, J. Appl. Polymer. Sci. 42:2141-2148. |
McCafferty et al., 1990, Phage antibodies: filamentous phage displaying antibody variable domains, Nature 348:552-554. |
Mendieta et al., 1996, Complementary sequence correlations with applications to reflectometry studies, Instrumentation and Development 3(6):37-46. |
Mickley, 2008, Steal Syndrome-strategies to preserve vascular access and extremity, Nephrol Dial Transplant 23:19-24. |
Miller et al., 2010, The MILLER banding procedure is an effective method for treating dialysis-associated steal syndrome, Kidney International 77:359-366. |
Milstein et al., 1983, Hybrid hybridomas and their use in immunohistochemistry, Nature 305:537-540. |
Mindlin et al., 1936, A force at a point of a semi-infinite solid, Physics, 7:195-202. |
Morrison et al., 1984, Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains, PNAS 81:6851-6855. |
Munson et al., 1980, Ligand: a versatile computerized approach for characterization of ligand-binding systems, Analytical Biochemistry, 107:220-239. |
Nezam, 2008, High Speed Polygon-Scanner-Based Wavelength-Swept Laser Source in the Telescope-Less Configurations with Application in Optical Coherence Tomography, Optics Letters 33(15):1741-1743. |
Nissen, 2001, Coronary Angiography and Intravascular Ultrasound, American Journal of Cardiology, 87(suppl):15A-20A. |
Nitenberg et al., 1995, Coronary vascular reserve in humans: a critical review of methods of evaluation and of interpretation of the results, Eur Heart J. 16(Suppl 1):7-21. |
Notice of Reason(s) for Refusal dated Apr. 30, 2013, for Japanese Patent Application No. 2011-508677 for Optical Imaging Catheter for Aberation Balancing to Volcano Corporation, which application is a Japanese national stage entry of PCT/US2009/043181 with international filing date May 7, 2009, of the same title, published on Nov. 12, 2009, as WO 2009/137704, and accompanying English translation of the Notice of Reason(s) for Refusal and machine translations of JP11-56786 and JP2004-290548 (56 pages). |
Nygren, 1982, Conjugation of horseradish peroxidase to Fab fragments with different homobifunctional and heterobifunctional cross-linking reagents. A comparative study, J. Histochem. and Cytochem. 30:407-412. |
Oesterle et al., 1986, Angioplasty at coronary bifurcations: single-guide, two-wire technique, Cathet Cardiovasc Diagn., 12:57-63. |
Okuno et al., 2003, Recent Advances in Optical Switches Using Silica-based PLC Technology, NTT Technical Review 1(7):20-30. |
Oldenburg et al., 1998, Nanoengineering of Optical Resonances, Chemical Physics Letters 288:243-247. |
Oldenburg et al., 2003, Fast-Fourier-Domain Delay Line for In Vivo Optical Coherence Tomography with a Polygonal Scanner, Applied Optics, 42(22):4606-4611. |
Othonos, 1997, Fiber Bragg gratings, Review of Scientific Instruments 68(12):4309-4341. |
Owens et al., 2007, A Survey of General-Purpose Computation on Graphics Hardware, Computer Graphics Forum 26(1):80-113. |
Pain et al., 1981, Preparation of protein A—peroxidase mono conjugate using a heterobifunctional reagent, and its use in enzyme immunoassays, J Immunol Methods, 40:219-30. |
Park et al., 2005, Real-time fiber-based multi-functional spectral-domain optical coherence tomography at 1.3 um., Optics Express 13(11):3931-3944. |
Pasquesi et al., 2006, In vivo detection of exercise induced ultrastructural changes in genetically-altered murine skeletal muscle using polarization-sensitive optical coherence tomography, Optics Express 14(4):1547-1556. |
Pepe et al., 2004, Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker, American Journal of Epidemiology 159(9):882-890. |
Persson et al., 1985, Acoustic impedance matching of medical ultrasound transducers, Ultrasonics, 23(2):83-89. |
Placht et al., 2012, Fast time-of-flight camera based surface registration for radiotherapy patient positioning, Medical Physics 39(1):4-17. |
Rabbani et al., 1999, Review: Strategies to achieve coronary arterial plaque stabilization, Cardiovascular Research 41:402-417. |
Radvany et al., 2008, Plaque Excision in Management of Lower Extremity Peripheral Arterial Disease with the SilverHawk Atherectomy Catheter, Seminars in Interventional Radiology, 25(1):11-19. |
Reddy et al., 1996, An FFT-Based Technique for Translation, Rotation, and Scale-Invariant Image Registration, IEEE Transaction on Image Processing 5(8):1266-1271. |
Riechmann et al., 1988, Reshaping human antibodies for therapy, Nature, 332:323-327. |
Rivers et al., 1992, Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique, Surgery, 112(3):593-7. |
Robbin et al., 2002, Hemodialysis Arteriovenous Fistula Maturity: US Evaluation, Radiology 225:59-64. |
Rollins et al., 1998, In vivo video rate optical coherence tomography, Optics Express 3:219-229. |
Sarunic et al., 2005, Instantaneous Complex Conjugate Resolved Spectral Domain and Swept-Source OCT Using 3×3 Fiber Couplers, Optics Express 13(3):957-967. |
Satiani et al., 2009, Predicted Shortage of Vascular Surgeons in the United States, J. Vascular Surgery 50:946-952. |
Schneider et al., 2006, T-banding: A technique for flow reduction of a hyper-functioning arteriovenous fistula, J Vase Surg. 43(2):402-405. |
Sen et al., 2012, Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis, Journal of the American College of Cardiology 59(15):1392-1402. |
Setta et al., 2005, Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis, Human Reproduction, 20(11):3114-3121. |
Seward et al., 1996, Ultrasound Cardioscopy: Embarking on New Journey, Mayo Clinic Proceedings 71(7):629-635. |
Shen et al., 2006, Eigengene-based linear discriminant model for tumor classification using gene expression microarray data, Bioinformatics 22(21):2635-2642. |
Abdi et al., 2010, Principal component analysis, Wiley Interdisciplinary Reviews: Computational Statistics 2:433-459. |
Adler et al., 2007, Phase-Sensitive Optical Coherence Tomography at up to 370,000 Lines Per Second Using Buffered Fourier Domain Mode-Locked Lasers, Optics Letters, 32(6):626-628. |
Agresti, 1996, Models for Matched Pairs, Chapter 8, An Introduction to Categorical Data Analysis, Wiley-Interscience A John Wiley & Sons, Inc., Publication, Hoboken, New Jersey. |
Akasheh et al., 2004, Development of piezoelectric micromachined ultrasonic transducers, Sensors and Actuators A Physical, 111:275-287. |
Amini et al., 1990, Using dynamic programming for solving variational problems in vision, IEEE Transactions on Pattern Analysis and Machine Intelligence, 12(9):855-867. |
Bail et al., 1996, Optical coherence tomography with the “Spectral Radar”—Fast optical analysis in volume scatterers by short coherence interferometry, Optics Letters 21(14):1087-1089. |
Bain, 2011, Privacy protection and face recognition, Chapter 3, Handbook of Face Recognition, Stan et al., Springer-Verlag. |
Barnea et al., 1972, A class of algorithms for fast digital image registration, IEEE Trans. Computers, 21(2):179-186. |
Blanchet et al., 1993, Laser Ablation and the Production of Polymer Films, Science, 262(5134):719-721. |
Bonnema, 2008, Imaging Tissue Engineered Blood Vessel Mimics with Optical Tomography, College of Optical Sciences dissertation, University of Arizona (252 pages). |
Bouma et al., 1999, Power-efficient nonreciprocal interferometer and linear-scanning fiber-optic catheter for optical coherence tomography, Optics Letters, 24(8):531-533. |
Breiman, 2001, Random forests, Machine Learning 45:5-32. |
Brown, 1992, A survey of image registration techniques, ACM Computing Surveys 24(4):325-376. |
Bruining et al., 2009, Intravascular Ultrasound Registration/Integration with Coronary Angiography, Cardiology Clinics, 27(3):531-540. |
Brummer, 1997, An euclidean distance measure between covariance matrices of speechcepstra for text-independent speaker recognition, in Proc. South African Symp. Communications and Signal Processing:167-172. |
Burr et al., 2005, Searching for the Center of an Ellipse in Proceedings of the 17th Canadian Conference on Computational Geometry:260-263. |
Canny, 1986, A computational approach to edge detection, IEEE Trans. Pattern Anal. Mach. Intell. 8:679-698. |
Cavalli et al., 2010, Nanosponge formulations as oxygen delivery systems, International Journal of Pharmaceutics 402:254-257. |
Choma et al., 2003, Sensitivity Advantage of Swept Source and Fourier Domain Optical Coherence Tomography, Optics Express 11(18):2183-2189. |
Clarke et al., 1995, Hypoxia and myocardial ischaemia during peripheral angioplasty, Clinical Radiology, 50(5):301-303. |
Collins, 1993, Coronary flow reserve, British Heart Journal 69:279-281. |
Communication Mechanisms for Distributed Real-Time Applications, NI Developer Zone, http://zone.ni.eom/devzone/cda/tut/p/id/3105, accessed Jul. 23, 2007. |
Cook, 2007, Use and misuse of receiver operating characteristic curve in risk prediction, Circulation 115(7):928-35. |
D'Agostino et al., 2001, Validation of the Framingham coronary heart disease prediction score: results of a multiple ethnic group investigation, JAMA 286:180-187. |
David et al., 1974, Protein iodination with solid-state lactoperoxidase, Biochemistry 13:1014-1021. |
Davies et al., 1985, Plaque fissuring—the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina, British Heart Journal 53:363-373. |
Davies et al., 1993, Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content, British Heart Journal 69:377-381. |
Deterministic Data Streaming in Distributed Data Acquisition Systems, NI Developer Zone, “What is Developer Zone?”, http://zone.ni.eom/devzone/cda/tut/p/id/3105, accessed Jul. 23, 2007. |
Eigenwillig, 2008, K-Space Linear Fourier Domain Mode Locked Laser and Applications for Optical Coherence Tomography, Optics Express 16(12):8916-8937. |
Elghanian et al., 1997, Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles, Science, 277(5329):1078-1080. |
Ergun et al., 2003, Capacitive Micromachined Ultrasonic Transducers:Theory and Technology, Journal of Aerospace Engineering, 16(2):76-84. |
Evans et al., 2006, Optical coherence tomography to identify intramucosa carcinoma and high-grade dysplasia in Barrett's esophagus, Clin Gast Hepat 4(1):38-43. |
Fatemi et al., 1999, Vibro-acoustography: an imaging modality based on ultrasound-stimulated acoustic emission, PNAS U.S.A., 96(12):6603-6608. |
Felzenszwalb et al., 2005, Pictorial Structures for Object Recognition, International Journal of Computer Vision, 61(1):55-79. |
Ferring et al., 2008, Vasculature ultrasound for the pre-operative evaluation prior to arteriovenous fistula formation for haemodialysis: review of the evidence, Nephrol. Dial. Transplant. 23(6):1809-1815. |
Fischler et al., 1973, The representation and matching of pictorial structures, IEEE Transactions on Computer 22:67-92. |
Fleming et al., 2010, Real-time monitoring of cardiac radio-frequency ablation lesion formation using an optical coherence tomography forward-imaging catheter, Journal of Biomedical Optics 15 (3):030516-1 (3 pages). |
Fookes et al., 2002, Rigid and non-rigid image registration and its association with mutual information:A review, Technical Report ISBN:1 86435 569 7, RCCVA, QUT. |
Forstner & Moonen, 1999, A metric for covariance matrices, In Technical Report of the Dpt of Geodesy and Geoinformatics, Stuttgart University, 113-128. |
Goel et al., 2006, Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) for treatment of dialysis access-associated steal syndrome, Kidney Int 70(4):765-70. |
Gotzinger et al., 2005, High speed spectral domain polarization sensitive optical coherence tomography of the human retina, Optics Express 13(25):10217-10229. |
Gould et al., 1974, Physiologic basis for assessing critical coronary stenosis, American Journal of Cardiology, 33:87-94. |
Griffiths et al., 1993, Human anti-self antibodies with high specificity from phage display libraries, The EMBO Journal, 12:725-734. |
Griffiths et al., 1994, Isolation of high affinity human antibodies directly from large synthetic repertoires, The EMBO Journal, 13(14):3245-3260. |
Grund et al., 2010, Analysis of biomarker data:logs, odds, ratios and ROC curves, Curr Opin HIV AIDS 5(6):473-479. |
Harrison et al., 2011, Guidewire Stiffness: What's in a name?, J Endovasc Ther, 18(6):797-801. |
Huber et al., 2005, Amplified, Frequency Swept Lasers for Frequency Domain Reflectometry and OCT Imaging: Design and Scaling Principles, Optics Express 13(9):3513-3528. |
Huber et al., 2006, Fourier Domain Mode Locking (FDML): A New Laser Operating Regime and Applications for Optical Coherence Tomography, Optics Express 14(8):3225-3237. |
International Search Report and Written Opinion dated Mar. 11, 2014, for International Patent Application No. PCT/US13/75675, filed Dec. 17, 2013 (7 pages). |
International Search Report and Written Opinion dated Mar. 19, 2014, for International Patent Application No. PCT/US13/075353, filed Dec. 16, 2013 (8 pages). |
Number | Date | Country | |
---|---|---|---|
20160015507 A1 | Jan 2016 | US |
Number | Date | Country | |
---|---|---|---|
61785204 | Mar 2013 | US |